Vol. 51, Issue 1, 63-82, March 1999

Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System

Institut Fédératif de Recherches Multidisciplinaires sur Les Peptides no. 23, Laboratoire de Neuroendocrinologie Cellulaire et Moléculaire, Institut National de la Santé et de la Recherche Médicale U 413, UA Centre National de la Recherche Scientifique, Université de Rouen, Mont-Saint-Aignan, France (A.G.M.-N., J.-L.D.-R., D.B., H.V.); and Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier de l'Université Laval, Quebec, Canada (V.L.-T., G.P.)

I. Introduction
II. Biochemical Pathways of Steroid Biosynthesis in Endocrine Glands
III. Cytochrome P-450scc
IV. 3-Hydroxysteroid Dehydrogenase
V. Cytochrome P-450c₁₇
VI. 17-Hydroxysteroid Dehydrogenase
VII. 5-Reductase
VIII. Aromatase
IX. Sulfotransferase and Sulfatase
X. 11-Hydroxysteroid Dehydrogenase
XI. Cytochrome P-45011
XII. Other Enzymes Involved in the Synthesis or Metabolism of Steroids
    A. 3-Hydroxysteroid Dehydrogenase
    B. ⁵-3-Hydroxysteroid Acyltransferase
    C. 7-Hydroxylase
    D. Cytochrome P-450-Aldosterone Synthase
XIII. Conclusion and Clinical Implications
XIV. Summary
Acknowledgments
References

	I. Introduction

Top Next References

Steroid hormones, which are synthesized in the adrenal gland, gonads and placenta, exert a large array of biological effects on the nervous system. In particular, steroid hormones play an important role in the development, growth, maturation, and differentiation of the central nervous system (CNS)² and peripheral nervous system (PNS) (for review, McEwen, 1994). Depending on their chemical nature and concentration, steroids can induce either protective or deleterious effects on nerve cells (Uno et al., 1989; Yu, 1989; Jones, 1993; Sapolsky, 1996; Green et al., 1997; Seckl, 1997; Kimonides et al., 1998). These actions had long been exclusively ascribed to steroids produced by endocrine glands, which can easily cross the blood-brain barrier to act on the CNS. However, a series of studies conducted by Baulieu and coworkers have shown that the rat brain is capable of synthesizing various steroid hormones such as pregnenolone (⁵P) and dehydroepiandrosterone (DHEA) from cholesterol (Baulieu, 1981). These authors first demonstrated the existence of high amounts of ⁵P and DHEA in the brain of castrated and adrenalectomized rats (Corpéchot et al., 1981, 1983). Thereafter, they found that the cerebral concentrations of ⁵P and DHEA are not affected by administration of adrenocorticotropic hormone or suppression of circulating glucocorticoids by dexamethasone (Robel and Baulieu, 1985). They also showed that the levels of ⁵P and DHEA in the brain undergo circadian variations which are not synchronized with those of circulating adrenal steroids (Robel et al., 1986). Finally, the immunohistochemical localization of cytochrome P-450 side chain cleavage (scc) in rat oligodendrocytes and the observation that the enzyme was biologically active (i.e., capable of converting cholesterol into ⁵P) unambiguously demonstrated that steroids can be synthesized within the CNS (Le Goascogne et al., 1987). The term neurosteroids has been coined to designate steroids that are newly synthesized from cholesterol or another early precursor in the nervous system, and are thus still present in substantial amounts after removal of peripheral steroidogenic glands (Robel and Baulieu, 1994). Neurosteroids occur in the nervous system as unconjugated steroids, sulfated esters of steroids, or fatty acid esters of steroids (Jo et al., 1989). These various forms of steroids are involved in the control of metabolic, behavioral, and psychical processes including cognition, stress, anxiety, and sleep (Majewska, 1992; Baulieu and Robel, 1996).

Besides their actions at the transcriptional level (McEwen, 1994), neuroactive steroids may act on nerve cells via two types of membrane receptors. Steroids can exert allosteric modulation of receptors for neurotransmitters such as -aminobutyric acid (GABA)_A receptors (Majewska, 1992), nicotinic receptors (Valera et al., 1992), muscarinic receptors (Klangkalya and Chan, 1988), N-methyl-D-asparate (NMDA) receptors (Wu et al., 1991), and  receptors (Monnet et al., 1995). In addition, it has been proposed that neuroactive steroids may act on nerve cells via proper membrane receptors coupled to G proteins (Orchinik et al., 1992) or through specific membrane sites using calcium as an intracellular messenger (Ramirez and Zheng, 1996). The recent demonstration that progesterone and 5-dihydroprogesterone directly inhibit oxytocin receptor function suggests that neurosteroids may also interact with various membrane-bound neuropeptide receptors (Grazzini et al., 1998).

	II. Biochemical Pathways of Steroid Biosynthesis in Endocrine Glands

Top Previous Next References

All steroid hormones derive from cholesterol which is provided by blood as low-density and high-density lipoproteins. A small proportion of cholesterol can also be produced directly in steroidogenic cells from acetate. The biochemical reactions responsible for the synthesis of steroids are controlled by various families of enzymes including hydroxylases (desmolases), oxydo-reductases (dehydrogenases), sulfotransferases (sulfokinases), and sulfuryl transferases (Fig. 1). Molecular cloning of the enzymes responsible for biosynthesis of steroid hormones has revealed, for some of these enzymes, the existence of multiple isoforms which are differentially expressed in steroidogenic tissues (Miller, 1988; Labrie et al., 1994). It has also been shown that various peripheral organs, such as the digestive tract (Dalla-Valle et al., 1992; Le Goascogne et al., 1995), the liver (Martel et al., 1994), and the prostate (Bélanger et al., 1989), can express at a low level the genes encoding several steroidogenic enzymes, suggesting that the production of bioactive steroids is not restricted to steroidogenic endocrine glands. The mechanisms regulating the expression of steroidogenic enzymes have been studied in great detail in the adrenal gland and gonads (Miller, 1988; Güse-Behling et al., 1992; Penning, 1997).

View larger version (35K): [in this window] [in a new window]   Fig. 1.   Biosynthesis of steroid hormones in endocrine glands. P-450scc, P450c17, 3-HSD, 17-HSD, 11OHase, 11-hydroxylase; 18OHase, 18-hydroxylase; 18-HSOR, 18-hydroxysteroid oxidoreductase; 21OHase, 21-hydroxylase.

	III. Cytochrome P-450scc

Top Previous Next References

The scc of cholesterol leading to the formation of ⁵P is catalyzed by cholesterol-desmolase, an enzymatic complex composed of cytochrome P-450scc (P-450scc) which possesses a hydroxylasic activity, adrenodoxine or ferredoxine, and adrenodoxine reductase (Fig. 1). Using an antibody raised against bovine adrenal P-450scc, Le Goascogne et al. (1987) have shown the presence of immunoreactive elements in the white matter throughout the rat brain, an observation which is rightly considered as the fundamental discovery that paved the way for further research on neurosteroids. The fact that glial cells in primary culture are capable of converting cholesterol into ⁵P has subsequently demonstrated that the immunoreactive P-450scc localized in the rodent brain actually corresponds to an active form of the enzyme (Jung-Testas et al., 1989). In addition, the occurrence of the mRNAs encoding for P-450scc and adrenodoxine has been evidenced in the CNS of mammals by means of various approaches including reverse transcription-polymerase chain reaction (RT-PCR), ribonuclease protection assays, and in situ hybridization (Mellon and Deschepper, 1993; Compagnone et al., 1995a). The P-450scc gene is expressed at a particularly high concentration in the cerebral cortex and, to a lesser extent, in the amygdala, hippocampus, and midbrain. The distribution of P-450scc mRNA is similar in the brain of female and male rats (Mellon and Deschepper, 1993; Compagnone et al., 1995a). The P-450scc gene is also expressed in the nervous system of developing rodent embryos, specifically in the cell lineages derived from the neural crest and in sensory structures of the PNS (Compagnone et al., 1995a). Recently, Ukena et al. (1998) have shown the presence of P-450scc in Purkinje cells of neonatal and adult rats, indicating that the gene is not only expressed in glial cells but also in neurons. The detection of relatively high amounts of ⁵P in the frog hypothalamus (Mensah-Nyagan et al., 1994) and the localization of an active form of P-450scc in the quail brain (Tsutsui and Yamazaki, 1995; Usui et al., 1995) have shown that the gene encoding P-450scc is also actively expressed in the CNS of nonmammalian vertebrates.

Recent studies have revealed the existence of substantial differences between the transcriptional factors regulating the expression of P-450scc in the C6 glial cell line and in steroid-secreting cells of endocrine glands (Mellon and Deschepper, 1993; Papadopoulos, 1993). Specifically, the steroidogenic factor SF-1, which plays a crucial role in the control of the expression of all steroid hydroxylase genes including P-450scc (Clemens et al., 1994; Ikeda et al., 1994), and the basal transcriptional factor Sp1 are not expressed in C6 glioma cells (Zhang et al., 1995). In fact, SF-1 has been detected in discrete cerebral areas which do not contain P-450scc mRNA (Mellon and Deschepper, 1993; Ikeda et al., 1994), indicating that SF-1 is not involved in the regulation of P-450scc gene expression in neural tissues as it is in steroidogenic glands. In contrast, cAMP which controls steroid biosynthesis in peripheral tissues (Moore et al., 1990; Watanabe et al., 1994) appears to modulate neurosteroidogenesis in C6 glioma cells (Papadopoulos and Guarneri, 1994). These observations reveal that the mechanisms regulating P-450scc gene expression in endocrine cells and nerve cells exhibit both differences and similarities.

Studies performed in rat indicate that the biological activity of P-450scc may be controlled by peripheral-type benzodiazepine receptor (PBR) ligands in the CNS (Guarneri et al., 1992) as previously shown in classical steroidogenic tissues (Krueger and Papadopoulos, 1990; Papadopoulos et al., 1990). In fact, PBRs, which facilitate the translocation of cholesterol from the external surface of mitochondria to the internal membrane, cause indirect stimulation of P-450scc activity (Papadopoulos, 1993). The observation that benzodiazepines activate neurosteroid biosynthesis has suggested that endogenous ligands of PBR (endozepines) could be involved in the regulation of P-450scc activity (Papadopoulos et al., 1992; Korneyev et al., 1993). The major natural ligand of PBR, diazepam-binding inhibitor (DBI), is a 11-kDa polypeptide whose gene is highly expressed in steroid-secreting tissues (Rhéaume et al., 1990; Brown et al., 1992; Rouet-Smih et al., 1992; Toranzo et al., 1994) as well as in C6 glioma cells (Alho et al., 1994) and in astrocytes (Tong et al., 1991; Malagon et al., 1992, 1993; Slobodyansky et al., 1992; Lihrmann et al., 1994; Patte et al., 1995; Lamacz et al., 1996). Proteolytic cleavage of DBI generates several bioactive peptides including the triakontatetraneuropeptide (TTN) DBI[17-50], the octadecaneuropeptide (ODN) DBI[33-50], and the triakontaseptaneuropeptide DBI[39-75] (Ferrero et al., 1986; Slobodyansky et al., 1994; Tonon et al., 1994; Patte et al., 1999). A study performed on isolated mitochondria from C6 glioma cells has revealed that DBI and TTN both stimulate the formation of ⁵P (Papadopoulos et al., 1992). These results strongly suggest that endozepines play an important role in the regulation of P-450scc activity in the nervous system.

	IV. 3-Hydroxysteroid Dehydrogenase

Top Previous Next References

The enzymatic complex 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase (3-HSD), which catalyzes the conversion of ⁵-3-hydroxysteroids into ⁴-3-ketosteroids, plays a crucial role in the biosynthesis of all classes of steroid hormones (Fig. 1). Molecular cloning of the cDNAs encoding 3-HSD has revealed the existence in human of two isoforms of the enzyme: type I 3-HSD which is mainly expressed in the placenta (Luu-The et al., 1989) and type II 3-HSD which is predominantly expressed in the adrenal gland and gonads (Rhéaume et al., 1991). Four types of 3-HSD cDNAs (types I-IV) have been characterized in the rat (Zhao et al., 1990, 1991; Mason, 1993) and six types (types I-VI) in the mouse (Simard et al., 1996; Abbaszade et al., 1997). The rodent type III 3-HSD isoform possesses the structural features common to all 3-HSD but does not display the expected classical 3-HSD activity; in fact, this isoenzyme behaves as a 3-ketosteroid reductase using NADPH as a cofactor, i.e., it is responsible for the conversion of saturated 3-ketosteroids into 3-hydroxy metabolites (Labrie et al., 1992). The enzyme 3-HSD is also present in various tissues such as the skin (Dumont et al., 1992), mammary gland (Rhéaume et al., 1991), and prostate (Bartsch et al., 1990).

The first data suggesting the existence of 3-HSD in the CNS have been provided by Weidenfield et al. (1980) who showed that homogenates of rat amygdala and septum are capable of converting ⁵P into progesterone. The formation of androstenedione from DHEA, which is also catalyzed by 3-HSD (Fig. 1), confirmed the presence of the enzyme in the rat brain (Robel et al., 1986). The biological activity of 3-HSD has also been detected in primary cultures of rodent oligodendrocytes (Jung-Testas et al., 1989) and neurons (Bauer and Bauer, 1989). The first immunohistochemical localization of 3-HSD in the CNS has been performed in the European green frog Rana ridibunda by using an antiserum raised against type I human placental 3-HSD (Mensah-Nyagan et al., 1994). This antiserum had been previously applied for the immunocytochemical localization of 3-HSD in classical steroid-producing organs of mammals such as the adrenal, testis, ovary, and placenta (Dupont et al., 1990a-c). Although the antibodies were raised against type I human placental 3-HSD (Luu-The et al., 1989), they also recognize other 3-HSD isotypes, in particular, type II 3-HSD (Dupont et al., 1990a-c) which is predominantly expressed in the adrenal and gonads (Lachance et al., 1991). It thus appears that the immunoreactive material detected in the frog brain may correspond to different variants of the 3-HSD family. The occurrence of large amounts of ⁴-3-ketosteroids (progesterone and 17-hydroxyprogesterone) in the frog brain and the capability of frog hypothalamic explants to catalyze the conversion of tritiated pregnenolone ([³H]⁵P) into progesterone demonstrate that the 3-HSD-immunoreactive material detected in the CNS actually corresponds to an active form of the enzyme (Mensah-Nyagan et al., 1994). In situ hybridization studies have revealed that the mRNAs encoding for 3-HSD in the rat brain are localized in the olfactive bulb, nucleus accumbens, hippocampus, area of medulla bordering the fourth ventricle as well as in the thalamus, hypothalamus, and cerebellum (Dupont et al., 1994; Guennoun et al., 1995). Immunocytochemical data have shown that, in the frog brain, the 3-HSD gene is exclusively expressed in neurons (Fig. 2). Similarly, in the rat CNS, 3-HSD mRNAs were only detected in neuronal cell bodies (Dupont et al., 1994; Guennoun et al., 1995) (Fig. 3). It should be noted however that the presence of 3-HSD and its mRNAs has recently been found in rodent Schwann cells by immunocytochemistry and RT-PCR (Guennoun et al., 1997). In addition, 3-HSD activity has been demonstrated in primary cultures of rat astrocytes and oligodendrocytes (Jung-Testas et al., 1989; Kabbadj et al., 1993). These observations indicate that glial cells, which do not possess 3-HSD in situ, may acquire the ability of expressing the 3-HSD genes when they are maintained in culture. Alternatively, it is possible that other 3-HSD isoenzymes distinct from isotypes I and II are present in brain glial cells. To solve this question, it will be necessary to identify the mRNAs encoding for the different 3-HSD isoforms in cultured rat astrocytes and oligodendrocytes.

View larger version (56K): [in this window] [in a new window]   Fig. 2.   Confocal laser scanning microscope photomicrographs of 3-HSD-immunoreactive neurons in the frog diencephalon. A, frontal section through the anterior preoptic area (Poa) showing 3-HSD-positive cell bodies close to the third ventricle (III). Original magnification, 700×. B, high magnification of a 3-HSD-immunoreactive neuron in the ventral hypothalamic nucleus (VH). Original magnification, 1300×.

View larger version (116K): [in this window] [in a new window]   Fig. 3.   Autoradiographic localization of 3-HSD mRNAs by in situ hybridization on frontal sections of the rat brain at the level of the nucleus prepositus hypoglossi. A, dense accumulation of silver grains is observed in a subpopulation of neurons (arrows) located in the vicinity of the fourth ventricle (V). Ependymal cells (E) do not express the 3-HSD gene. Original magnification, 560×. B, pretreatment of the brain section with RNase abolished autoradiographic labeling. Original magnification, 560×. Reprinted from Dupont et al. (1994) with permission from Academic Press, Inc.

The mechanisms of regulation of 3-HSD gene transcription have been extensively studied in peripheral steroidogenic tissues (Labrie et al., 1994; Guérin et al., 1995; Mason et al., 1997). In contrast, until recently, nothing was known concerning the control of 3-HSD activity in the CNS. The observation that, in the frog, numerous hypothalamic neurons contain simultaneously 3-HSD- and PBR-like imunoreactivities (Do-Régo et al., 1998) suggested that the endogenous ligands of PBR may control 3-HSD activity. As a matter of fact, it was found that the endozepine TTN causes a dose-dependent stimulation of the conversion of ⁵P into 17-hydroxyprogesterone, indicating that TTN enhances 3-HSD activity (Do-Régo et al., 1998). The effect of TTN was mimicked by the PBR agonist 4'-chlorodiazepam and inhibited by the PBR antagonist 1-(2-chlorophenyl)-N-methyl-N-(1-methyl-propyl)-3-isoquinoline carboxamide (PK11195; Benavides et al., 1984; Zavala and Lenfant, 1987; Costa et al., 1994). In contrast, flumazenil, a central-type benzodiazepine receptor antagonist (Brodgen and Goa, 1991), did not affect TTN-evoked neurosteroid secretion (Do-Régo et al., 1998) (Fig. 4). Altogether, these data indicate that TTN stimulates the biological activity of 3-HSD in hypothalamic neurons through activation of PBR likely located at the plasma membrane level.

View larger version (27K): [in this window] [in a new window]   Fig. 4.   Effect of the triakontatetraneuropeptide TTN and other benzodiazepine receptor ligands on the conversion of [3H]5P into 4-3-ketoneurosteroids. Frog hypothalamic explants were incubated for 2 h with 24 µCi/ml of [3H]5P and the radioactive newly synthesized 4-3-ketosteroids were separated by HPLC analysis. The endozepine TTN and the PBR agonist Ro-5-4864 both induced a marked increase of neurosteroid biosynthesis. The PBR antagonist PK11195 (104 M) reduced the basal synthesis of neurosteroids and significantly attenuated the effect of TTN. The central-type benzodiazepine receptor antagonist flumazenil (105 M) also reduced the basal synthesis of neurosteroids but did not affect the stimulatory action of TTN on 4-3-ketoneurosteroid formation. P < .05; , P < .01; , P < .001; NS, not statistically different.

	V. Cytochrome P-450c17

Top Previous Next References

The enzymatic system 17-hydroxylase/17,20 lyase (cytochrome P-450c₁₇) is responsible for the transformation of C₂₁ steroids (⁵P, progesterone) into C₁₉ steroids (DHEA and androstenedione, respectively) (Fig. 1). It is now clearly demonstrated that, in classical steroid-producing glands, these reactions are catalyzed by a single microsomal enzyme coupled to a cytochrome reductase, cytochrome P-450c₁₇ (P-450c₁₇ or P-450₁₇), which possesses both 17-hydroxylase and 17,20 lyase activities. The lyase bioactivity of this enzymatic complex is modulated by phosphorylation and depends on the lipidic environment (Nakajin et al., 1981; Miller, 1988; Namiki et al., 1988).

The early observation that the rat brain contains high concentrations of DHEA (Corpéchot et al., 1981) suggested the existence of P-450c₁₇ activity in the CNS of mammals. However, biochemical and immunocytochemical studies aimed at demonstrating the presence of the enzyme in the brain have long remained unsuccessful (Baulieu and Robel, 1990; Le Goascogne et al., 1991; Mellon and Deschepper, 1993). In 1994, it was demonstrated that frog hypothalamic explants are capable of converting [³H]⁵P into [³H]17-hydroxyprogesterone (Mensah-Nyagan et al., 1994). This observation provided the first evidence for the presence of P-450c₁₇ in the CNS. Subsequently, P-450c₁₇ mRNAs have been detected by RT-PCR in the brain of rat embryos (Compagnone et al., 1995b). P-450c₁₇-like immunoreactivity has also been observed in various neuronal populations of the pontine nucleus, the locus ceruleus and the spinal cord in mouse embryos. In contrast, conflicting data have been reported in adults: according to Compagnone et al. (1995b), P-450c₁₇ gene is only expressed in the PNS of rat and mouse, whereas other studies have described the presence of P-450₁₇ mRNAs in various brain regions of adult rodents (Strömstedt and Waterman, 1995).

The regulation of P-450c₁₇ gene expression in peripheral steroidogenic tissues is controlled by androgens (Burgos-Trinidad et al., 1997), insulin-like growth factor type I (Naseeruddin and Hornsby, 1990), catecholamines (Ehrhart-Bornstein et al., 1991; Güse-Behling et al., 1992; Haidan et al., 1998), cAMP, and protein kinase C activators (McAllister and Hornsby, 1988; Cheng et al., 1992). In contrast, the mechanisms regulating the expression of the P-450c₁₇ gene in the brain of mammals have not yet been determined. In a recent study, it has been shown that, in the frog hypothalamus, TTN stimulates the conversion of [³H]⁵P into [³H]17-hydroxyprogesterone, indicating that endozepines can increase P-450c₁₇ activity in nerve cells (Do-Régo et al., 1998).

	VI. 17-Hydroxysteroid Dehydrogenase

Top Previous Next References

The enzyme 17-HSD plays a pivotal role in the biosynthesis and the inactivation of sex steroid hormones by catalyzing the interconversion of 17-ketosteroids (androstenedione, estrone) and 17-hydroxysteroids (testosterone, 17-estradiol) (Fig. 1). Molecular cloning of the 17-HSD cDNAs and biochemical characterization of the enzyme activity have revealed the existence of seven isoforms designated types I to VII (Andersson, 1995; Blomquist, 1995; Andersson and Moghrabi, 1997; Biswas and Russell, 1997; Nokelainen et al., 1998). Type I, III, and V isoenzymes catalyze almost exclusively reductive reactions, leading to the formation of active steroids such as testosterone and 17-estradiol. Conversely, the type II and IV isoenzymes, which preferentially catalyze the oxidative reaction, are responsible for the synthesis of androstenedione and estrone (Andersson, 1995). Type VI 17-HSD oxidizes essentially 5-androstane-3,17-diol to androsterone. This latter 17-HSD isoform shares 65% sequence identity with retinol dehydrogenase 1 which catalyzes the oxidation of retinol to retinal (Biswas and Russell, 1997). Type VII 17-HSD, which catalyzes the conversion of estrone to estradiol, has been initially described as a prolactin receptor-associated protein because of a high (89%) sequence homology (Duan et al., 1996, 1997; Nokelainen et al., 1998). Recently, it has been shown that the Ke 6 protein, which is intimately linked to the development of cysts in the kidney and liver (Aziz et al., 1996), efficiently catalyzes the reduction of estrone and also the oxidation of estradiol and testosterone in an NAD-dependent manner, indicating that the Ke 6 protein is a potential eighth member of the 17-HSD isozyme family (Fomitcheva et al., 1998). Five isoforms of 17-HSD have been cloned in humans and their cDNAs structurally characterized. Type I 17-HSD, which was isolated for the first time from a human placental library, has subsequently been identified in the ovary and mammary gland (Martel et al., 1992). The type II isoenzyme, which was isolated from prostate and placental cDNA libraries, is also present in the endometrium, liver, small intestine as well as in the kidney, pancreas, and colon (Casey et al., 1994). In contrast, the type III 17-HSD gene is exclusively expressed in the testis (Geissler et al., 1994). Molecular cloning of human type IV 17-HSD revealed that this isoenzyme is expressed in the liver, kidney and, to a lesser extent, in the endometrium and testis (Adamski et al., 1995). Recently, the cDNA encoding for the type V 17-HSD isoenzyme has been characterized in humans using a placental cDNA library (Labrie et al., 1997). Different isoforms of 17-HSD were also detected in various peripheral tissues of rodents (Normand et al., 1995) and pig (Adamski et al., 1992; Leenders et al., 1994a,b).

The existence of a 17-HSD activity in the mammalian brain has long been known (Reddy, 1979; Resko et al., 1979) but it is only recently that the cellular distribution of the enzyme in the CNS has been described (Pelletier et al., 1995). Immunocytochemical mapping of 17-HSD has also been determined in the frog brain using antibodies against human placental type I 17-HSD (Mensah-Nyagan et al., 1996a,b). In the CNS of both mammals and amphibians, type I 17-HSD is exclusively expressed in glial cells (Pelletier et al., 1995; Mensah-Nyagan et al., 1996a,b) (Fig. 5). In the rat brain, 17-HSD-like immunoreactivity is widely distributed in ependymocytes and astrocytes of the hippocampus, cerebral cortex, thalamus, and hypothalamus, whereas, in the frog brain, the immunoreactive material is only located in ependymocytes of the telencephalon. Whether these species differences reflect authentic variations in the anatomical distribution of 17-HSD in the CNS of mammals and amphibians or whether they can be ascribed to the presence, in the frog brain, of distinct 17-HSD isoforms which cannot be detected with the antibodies against type I 17-HSD remains unkown. In this respect, it should be noticed that the five isoforms of 17-HSD cloned in various vertebrate species do not exhibit the same cellular distribution or functional characteristics in peripheral steroidogenic tissues (Andersson, 1995; Andersson and Moghrabi, 1997; Puranen et al., 1997). In addition, in the CNS of mammals, 17-HSD is mainly involved in the inactivation of sex steroid hormones (Reddy, 1979; Resko et al., 1979; Martini et al., 1996), whereas, in the brain of amphibians, this enzyme is responsible for the synthesis of testosterone (Mensah-Nyagan et al., 1996a,b). In the frog Rana ridibunda, a series of observations have demonstrated that biosynthesis of testosterone actually occurs in the CNS: 1) high amounts of testosterone have been detected in the medial pallium and the hypothalamus, and the concentrations of testosterone are not affected by castration; 2) endogenous testosterone extracted from the telencephalon has been chemically characterized by combining HPLC analysis, gas chromatography and mass spectrometry; and finally 3) synthesis of [³H]testosterone and [³H]5-DHT from [³H]⁵P by frog telencephalon explants has been demonstrated in vitro (Mensah-Nyagan et al., 1996a,b). Formation of androgens and estrogens from a distant precursor such as [³H]⁵P or [³H]DHEA has also been shown in primary cultures of avian nerve cells (Vanson et al., 1996), indicating that 17-HSD-like activity responsible for the synthesis of sex steroids is present in the CNS of various groups of vertebrates. Taken together, these data suggest the expression of new classes of 17-HSD isoforms in the nervous system of nonmammalian vertebrates or the occurrence of a biological activity distinct from that of 17-HSD isoenzymes present in the mammalian brain. Molecular cloning of the various 17-HSD genes in representative submammalian species is clearly required to investigate their expression in the CNS.

View larger version (78K): [in this window] [in a new window]   Fig. 5.   Immunocytochemical localization of 17-HSD in the CNS of rat and frog. A, 17-HSD-positive glial cells in the rat cerebellar cortex (CC). Reprinted from Pelletier et al. (1995) with kind permission from Elsevier Science-NL (Sara Burgerhartstraat 25, 1055 KV Amsterdam, the Netherlands). Original magnification, 80×. B, 17-HSD-immunoreactive ependymal cells bordering the lateral ventricle (V) in the frog telencephalon. MP, medial pallium. Original magnification, 500×.

In peripheral tissues, the expression of 17-HSD is regulated at the transcriptional level by sex steroid hormones (Peltoketo et al., 1996), growth factors (Ghersevich et al., 1994; Jantus-Lewintre et al., 1994), retinoic acid (Piao et al., 1995), and cAMP (Tremblay and Baudouin, 1993). Whether these different factors are also involved in the control of 17-HSD gene expression in nerve cells has not yet been investigated.

	VII. 5-Reductase

Top Previous Next References

The enzyme 5-reductase (5-R) is a microsomal NADPH-dependent protein which acts specifically on steroids possessing a C₄-C₅ double bond and a ketone group at the C₃ position. This enzyme catalyzes the transfer of two hydrogens from NADPH causing the reduction of the C₄-C₅ double bond and the formation of 5-reduced metabolites. In particular, 5-R catalyzes the conversion of testosterone, the main circulating androgen, into dihydrotestosterone (5-DHT) and the transformation of progesterone into dihydroprogesterone (5-DHP) (Fig. 1). In humans, two distinct cDNAs encoding type I and type II 5-R have been cloned from a prostate library; these cDNAs exhibit an overall sequence identity of 60% (Andersson and Russell, 1990; Andersson et al., 1991). The 5-RI gene, located on chromosome 5, is mainly expressed in the skin (Luu-The et al., 1994), notably in the pubic skin and the scalp (Andersson and Russell, 1990; Jenkins et al., 1992). The 5-RII gene is predominantly expressed in the prostate and gonads (Thigpen et al., 1993; Luu-The et al., 1994; Mowszowicz et al., 1995). Deletion in the 5-RII gene causes male pseudohermaphroditism, indicating that 5-RII is involved in the determination of the sexual phenotype during embryogenesis (Andersson et al., 1991). In rat, 5-RI and 5-RII cDNAs have been cloned from a prostate library but the two genes are actually transcribed in distinct cell types: 5-RI mRNAs are localized in the basal epithelial cells whereas 5-RII mRNAs are found in stromal cells (Andersson and Russell, 1990; Berman and Russell, 1993).

In vitro studies have shown the existence of 5-R bioactivity in brain tissue and specially in primary cultures of nerve cells (Saitoh et al., 1982; Melcangi et al., 1993; Martini et al., 1996; Negri-Cesi et al., 1996a,b). Northern blot analysis has shown the occurrence of high concentrations of 5-RI mRNAs but relatively low amounts of 5-RII mRNAs in rat brain extracts (Normington and Russell, 1992; Lephart, 1993). The anatomical distribution of 5-R in the rat brain was first investigated using an antibody raised against human 5-RI (Luu-The et al., 1994). The presence of 5-R-like immunoreactivity has been found in astrocytes, ependymocytes, and tanycytes within various brain regions including the hypothalamus, thalamus, hippocampus, cerebral cortex, and circumventricular organs (Pelletier et al., 1994). At the ultrastructural level, the immunoreactive material appeared to be distributed throughout the cytoplasm of glial cells without any particular association with mitochondria (Pelletier et al., 1994). This observation is consistent with previous subcellular fractionation studies which had shown that 5-R activity was mostly associated with the microsomal fraction (Lephart, 1993). Using an antibody raised against rat 5-RI, Tsuruo et al. (1996) have recently reported that 5-R-like immunoreactivity is mainly contained in oligodendrocytes of the white matter and in ependymocytes bordering the cerebral ventricles. Collectively, these data indicate that, in the CNS of mammals, the 5-R gene is primarily expressed in glial cells. However, biochemical studies have shown that neurons from rat embryos in primary culture exhibit 5-R activity (Melcangi et al., 1994). These observations suggest that the 5-R genes may be transcribed in distinct cell types of the CNS according to development stages. Alternatively, the expression of the 5-R genes may be up-regulated in cultured neurons.

In all classes of vertebrates, conversion of gonadal testosterone into 5-DHT in the brain of male individuals is necessary for the induction of various behavioral effects. Since the occurrence of 17-HSD-like immunoreactivity has been demonstrated within glial cells in the frog brain (Mensah-Nyagan et al., 1996a,b), it would be interesting to investigate the cellular localization of 5-R in the CNS of amphibians to examine whether the same cells may simultaneously synthesize testosterone and convert it into 5-DHT. Concurrently, in the mammalian brain, the consecutive catalytic actions of 5-R and 3-hydroxysteroid dehydrogenase on progesterone leads to the formation of allopregnanolone (Baulieu et al., 1996), a potent modulator of GABA_A receptors, which controls various psychical processes (Schumacher et al., 1996; Patchev et al., 1996). Expression of the 5-R gene in nerve cells may thus have important implications in the control of neurophysiological functions in vertebrates.

Neuroanatomical studies have revealed that, in mammals, 5-R is present in various regions of the CNS where androgen (Arnold and Gorski, 1984; Clark et al., 1988; Roselli et al., 1996a,b) and estrogen receptors are located (Pelletier et al., 1988; Balthazart et al., 1989; Torran-Allerand et al., 1992; Yuan et al., 1995). However, it is generally accepted that, in the brain, there is no sexual dimorphism in the expression of 5-R; in addition, castration or sex steroid hormone administration does not affect 5-R activity (Wilson, 1975; Celotti et al., 1983; Lephart, 1993; Negri-Cesi et al., 1996b). A remarkable exception has been reported in monkey in which castration induces a selective increase of the biological activity of 5-R in the basolateral amygdala but not in other regions of the CNS (Roselli et al., 1987). These observations suggest that, in discrete brain areas, sex steroids may control 5-R expression and/or activity as described in the rat adrenal gland (Lephart et al., 1991). Concurrently, suppression of hypothalamic (nor-) adrenergic neurotransmission by pharmacological blockers and surgical deafferentation of the hypothalamus do not affect 5-R activity, indicating that the expression of the enzyme is not regulated by extrinsic neural inputs (Celotti et al., 1983). However, incubation of glial cells with 8Br-cAMP, but not phorbol esters, causes a significant increase of 5-DHT formation (Celotti et al., 1992; Negri-Cesi et al., 1996b). These data suggest that a protein kinase A is involved in the regulation of 5-R activity in nerve cells, although the neural factors responsible for the activation of this transduction pathway remain unknown.

	VIII. Aromatase

Top Previous Next References

The conversion of androgens into estrogens is catalyzed by aromatase (Fig. 1), an enzymatic complex which comprises two proteins, i.e., a specific form of cytochrome (cytochrome P-450aromatase) responsible for the binding of the C₁₉ steroid substrate and the formation of the phenolic A-ring characteristic of estrogens, and a flavoprotein (NADPH-cytochrome P-450reductase) which transfers reducing equivalents from NADPH to any microsomal form of cytochrome (for review, Nelson et al., 1993). Aromatase activity occurs in various tissues including the placenta (Fournet-Dulguerov et al., 1987), ovary (McNatty et al., 1976; Lephart et al., 1995), testis (Fritz et al., 1976; Valladares and Payne, 1979; Levallet and Carreau, 1997), and adipocytes (Simpson et al., 1989). The aromatase gene, which has been cloned in humans, is composed of 17 exons and is localized at the q21.1 level of chromosome 15 (Means et al., 1989; Harada et al., 1990; Toda et al., 1990). Molecular cloning of aromatase cDNAs in various vertebrate taxa has revealed the existence of a single enzyme in most species including trout (Tanaka et al., 1992), chicken (McPhaul et al., 1988), rat (Hickey et al., 1990), mouse (Terashima et al., 1991), bovine (Hinshelwood et al., 1993), and humans (Corbin et al., 1988; Harada, 1988). A remarkable exception has been reported in pig which possesses two distinct isoforms of aromatases (Corbin et al., 1995; Conley et al., 1997).

It has long been known that conversion of androstenedione into estrone occurs in the rat brain, indicating the presence of aromatase activity in the CNS (Naftolin et al., 1972, 1975; Roselli et al., 1985). Immunocytochemical studies have recently shown that aromatase is expressed in neurons and not in glial cells (Lephart, 1996). In the brain of birds, a good correlation has been observed between the localization of aromatase-like immunoreactivity and the distribution of aromatase activity. Particularly, in the Japanese quail, aromatase-positive neurons are located in the preoptic area where an intense enzymatic activity is also found (Balthazart et al., 1990a,b, 1991b, 1992). Conversely, in mammals, especially in rodents, mismatches have been reported between the localization of aromatase-positive neurons and the distribution of enzymatic activity in the CNS. For instance, high levels of aromatase activity are detected in the median preoptic area and the ventromedian nucleus of rat, two regions which are virtually devoid of aromatase-immunoreactive neurons (Shinoda et al., 1989a,b; Balthazart et al., 1991a; Sanghera et al., 1991). It should be noted however that, during ontogenesis, aromatase-positive neurons have been visualized in the preoptic area, the ventromedian nucleus and the arcuate nucleus at embryonic day 13 (E₁₃), E_16, and E₁₉, respectively. In these regions, the number of aromatase-positive neurons increases during gestation, peaks before birth, and decreases or vanishes during the two first postnatal weeks (Tsuruo et al., 1994). These data reveal the existence of spatio-temporal variations in the level of transcription of the aromatase gene during development.

The mechanisms controlling aromatase expression and bioactivity in the CNS have been investigated during ontogenesis and in the adult. Because of the high affinity of the enzyme for testosterone, various research groups have examined the effects of androgens on aromatase gene transcription during embryogenesis (Callard et al., 1980; Paden and Roselli, 1987; Lephart et al., 1992; Roselli and Resko, 1993). Their studies revealed that, in rodent embryos, neither testosterone nor 5-DHT had any influence on aromatase gene expression in cultured hypothalamic neurons (Abe-Dohmae et al., 1994; Negri-Cesi et al., 1996a). In contrast, aromatase activity in the CNS appears to be modulated by androgens, although controversial data have been reported in the literature: Lephart et al. (1992) have observed that androgens are capable of reducing aromatase activity in rat embryo hypothalamic explants, whereas Beyer et al. (1994b) have described a stimulatory effect of testosterone on estrogen formation in cultured mouse fetal diencephalic neurons. Depending on the species and/or the environmental milieu, androgens may thus exert opposite effects on aromatase activity in the developing brain. In adult individuals, androgens clearly play a crucial role in the regulation of aromatase gene transcription and aromatase activity in the CNS of amphibians (Moore et al., 1994), birds (Harada et al., 1992; Panzica et al., 1996), and mammals (Negri-Cesi et al., 1996a,b). In particular, it has been demonstrated that castration significantly reduces the amount of aromatase mRNAs and activity in the quail (Harada et al., 1992) and rat brain (Abdelgadir et al., 1994; Roselli et al., 1997). Reciprocally, administration of testosterone increases the level of aromatase mRNA and the number of aromatase-immunoreactive neurons (Harada et al., 1992; Abdelgadir et al., 1994), indicating the importance of testosterone in the regulation of aromatase expression in the CNS. Since estrogens stimulate the expression of androgen receptors and increase the duration of androgen receptor occupation in the rat brain (Roselli and Fasasi, 1992), it is conceivable that estrogens and androgens may exert a coordinate action in the control of aromatase gene expression in the CNS. Concurrently, an effect of dopamine on aromatase activity has been demonstrated in the quail preoptic area, indicating that neurotransmitters may regulate reproductive behavior by modulating estrogen formation in the brain (Baillien and Balthazart, 1997). Finally, the fact that a large population of aromatase-positive neurons are located in the preoptic-septal complex (Shinoda et al., 1989b; Balthazart et al., 1990a,b, 1991a,b; Sanghera et al., 1991; Jakab et al., 1993, 1994; Beyer et al., 1994a,c; Foidart et al., 1995), where a number of neuropeptides controlling sexual behavior are present (Wehrenberg et al., 1989; DeVries, 1990; Kalra et al., 1990; Kawata et al., 1991; Albers et al., 1992; Andersen et al., 1992; King and Millar, 1992; Sherwood et al., 1993; Winslow et al., 1993; Moore et al., 1994), suggests that some of these neuropeptides could be involved in the regulation of aromatase gene transcription and/or activity in the CNS.

	IX. Sulfotransferase and Sulfatase

Top Previous Next References

Sulfate conjugation of steroids is catalyzed by sulfotransferases or sulfokinases, a family of cytosolic enzymes which transfer the sulfate moiety from the universal donor molecule 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a hydroxyl group of the steroid substrates. In contrast, sulfatase is responsible for the hydrolysis of sulfated steroids leading to the formation of unconjugated steroids (Fig. 1). Hydroxysteroid sulfonates act as potent regulators of neuronal activity. In particular, pregnenolone sulfate (⁵PS) and dehydroepiandrosterone sulfate (DHEAS) modulate the functions of GABA_A receptors (Majewska, 1992), NMDA receptors (Wu et al., 1991; Weaver et al., 1997),  receptors (Monnet et al., 1995), and voltage-gated calcium channels (Ffrench-Müllen and Spence, 1991; Ffrench-Müllen et al., 1994). The fact that the inhibitory action of ⁵PS on calcium channel currents in pyramidal neurons is abolished after substitution of the sulfate moiety by an acetate (Ffrench-Müllen et al., 1994) demonstrates the importance of the sulfate group in the neurogenic activity of 3-hydroxysteroids.

Molecular cloning of sulfotransferase cDNAs has revealed the existence of multiple isoforms which have differential affinity for various steroid substrates and are expressed in a tissue-specific manner. The steroid sulfotransferase superfamily comprises four classes of enzymes: 1) hydroxysteroid sulfotransferases (HST) that act on primary and secondary alcohols of hydroxysteroids such as cholesterol, ⁵P and DHEA, 2) estrone sulfotransferases that transfer the sulfonate moiety on the 3-hydroxyl group of estrogens, 3) steroid sulfotransferases that have a broad specificity, and 4) cortisol sulfotransferases that act on the 21-hydroxyl group of glucocorticosteroids (for reviews, Webb, 1992; Strott, 1996).

The human sulfatase gene has been cloned and mapped to the Xp22.3 chromosome, proximal to the pseudoautosomal region (Ballabio and Shapiro, 1995). Recent molecular cloning studies have also characterized the complete gene of rat sulfatase (Li et al., 1996) and a mouse sulfatase cDNA (Salido et al., 1996). These results revealed that the overall genomic organization of rat and human sulfatases is very similar, except that the insertion site for intron 1 in the rat is 26 bp upstream from that in humans.

The existence of sulfotransferase-like activity has long been demonstrated in the primate brain (Knapstein et al., 1968). Similarly, early studies have shown the occurrence of sulfatase bioactivity in the CNS of vertebrates including human (Kishimoto and Sostek, 1972; Iwamori et al., 1976). Consistent with these findings, high amounts of ⁵P, DHEA, and their sulfated esters (⁵PS and DHEAS) have been detected in the brain of castrated and adrenalectomized rats, suggesting the presence of sulfotransferase and sulfatase activities in the CNS (Corpéchot et al., 1981, 1983). In vitro studies have confirmed the existence of sulfotransferase (Rajkowski et al., 1997) and sulfatase bioactivity (Park et al., 1997) in the mammalian brain. However, the anatomical localization of these enzymes in the brain of vertebrates has long remained unknown. Recently, the cellular distribution of sulfotransferase has been investigated in the CNS of the European green frog Rana ridibunda using an antiserum raised against rat liver HST (Beaujean et al., 1999). Two populations of HST-immunoreactive neurons have been detected in the anterior preoptic area and in the magnocellular preoptic nucleus of the hypothalamus. A dense bundle of HST-positive glial processes is also present in the ventral hemispheric zone. In addition, frog telencephalon and hypothalamus homogenates are capable of synthesizing ⁵PS and DHEAS (Fig. 6), as demonstrated by pulse-chase experiments using [³⁵S]PAP and [³H]⁵P or [³H]DHEA as precursors (Beaujean et al., 1999). Concurrently, the presence of sulfatase mRNAs has been visualized in the cortex, hindbrain, and thalamus of mouse fetuses during the last week of gestation (Compagnone et al., 1997). In the adult bovine brain, sulfatase activity is particularly abundant in the midbrain and hypothalamus (Park et al., 1997), suggesting that the sites of expression of the enzyme in the CNS may vary during development and/or may differ from one species to the other. These studies indicate that brain neurons and/or glial cells express both sulfotransferase and sulfatase activities which play an important role in the regulation of the functions of neuroactive steroids.

View larger version (17K): [in this window] [in a new window]   Fig. 6.   Biosynthesis of 5PS (A) and DHEAS (B) in the frog hypothalamus in vitro. Frog hypothalamic homogenates were incubated for 3 h with [3H]5P and [35S]PAPS (A) or with [3H]DHEA and [35S]PAPS (B). The steroids were extracted in a mixture of water and dichloromethane (v/v) and the aqueous phase, containing sulfated steroids, was analyzed by HPLC using a hexane/tetrahydrofuran (THF) gradient. The ordinates indicate the radioactivity (3H and 35S) measured in the HPLC fractions. The dashed linerepresents the gradient of secondary solvent (% THF). The arrows indicate the elution position of standard steroids. Reprinted from Beaujean et al. (1999) with permission from the Journal of Neurochemistry, Lippincott-Raven Publishers.

	X. 11-Hydroxysteroid Dehydrogenase

Top Previous Next References

The transformation of physiologically active glucocorticoids (cortisol, corticosterone) into inactive metabolites (cortisone, 11-dehydrocorticosterone) is catalyzed by 11-hydroxysteroid dehydrogenase (11-HSD), a microsomal NADP⁺-dependent enzyme. High levels of 11-HSD activity are present in the kidney and salivary gland (Edwards et al., 1988; Monder et al., 1989), as well as in the liver, lung, and testis (Phillips et al., 1989). Molecular cloning of the cDNAs encoding 11-HSD revealed the existence of two isoforms of the enzyme (type I 11-HSD or 11-HSDI and type II 11-HSD or 11-HSDII) in humans (Tannin et al., 1991; Albiston et al., 1994), sheep (Yang et al., 1992; Agarwal et al., 1994), rat (Agarwal et al., 1989; Zhou et al., 1995), and mouse (Rajan et al., 1995; Cole, 1995). Type I 11-HSD isozyme utilizes NADPH as a cofactor and is capable of functioning (in addition of the classical 11-HSD activity) as an 11-reductase by regenerating active glucocorticoids in cultured cells (Agarwal et al., 1989; Duperrex et al., 1993; Low et al., 1994). Type II 11-HSD is an exclusive glucocorticoid-inactivating enzyme whose bioactivity is NAD-dependent (Brown et al., 1993; Rusvai and Naray-Fejes-Toth, 1993).

The presence of 11-HSD activity has been demonstrated in various areas of the CNS including the cerebellum, hippocampus, neocortex, amygdala, and brainstem (Grosser and Axelrod, 1968; Miyabo et al., 1973; Moisan et al., 1990, 1992; Lakshmi et al., 1991). Northern blot analysis, using a rat liver 11-HSDI cDNA probe has revealed the presence of a single mRNA band in the rat brain (Moisan et al., 1990, 1992). The 11-HSDI gene is actively expressed in various neuronal populations of the cerebellum, hippocampus, cerebral cortex, and hypothalamus (Moisan et al., 1992). The location of 11-HSDI mRNA in these brain areas coincides exactly with the regional distribution of the enzymatic activity (Lakshmi et al., 1991). Northern blot experiments using human kidney and placental 11-HSDII cDNAs did not reveal the presence of type II 11-HSD mRNAs in the whole human brain (Albiston et al., 1994; Brown et al., 1996). In contrast, a recent in situ hybridization study has revealed that the 11-HSDII gene is expressed in discrete areas of the rat brain including the commissural portion of the nucleus tractus solitarius and the subcommissural organ (Roland et al., 1995). These data show the existence of important species differences in the expression of the 11-HSD in the brain.

The regulation of 11-HSD gene expression remains largely unknown. It has been recently reported that chronic treatment with dexamethasone and stress increase 11-HSD activity in the hippocampus, but not in the kidney (Seckl et al., 1993), suggesting that 11-HSD may contribute to the protection of hippocampal neurons against the deleterious effects provoked by glucocorticoid excess (for review, Seckl, 1997).

	XI. Cytochrome P-45011

Top Previous Next References

The enzyme 11-hydroxylase, or cytochrome P-45011 (P-45011), catalyzes the formation of glucocorticosteroids (cortisol and corticosterone). The P-45011 gene is only expressed in the zona fasciculata reticularis of the adrenal cortex (Yabu et al., 1991; Ogishima et al., 1992; Ho and Vinson, 1993; Mitani et al., 1995; Erdmann et al., 1995).

The presence of P-45011 in the CNS was first demonstrated in rat by immunohistochemistry using polyclonal antibodies raised against purified bovine adrenocortical P-45011. This study revealed that P-45011-like immunoreactivity is selectively localized to the tracts of myelinated fibers throughout the brain (Ozaki et al., 1991). Enzymatic assays for P-45011 monooxygenase activity as well as the 11-hydroxylation of [4-¹⁴C]11-deoxycorticosterone in brain homogenates demonstrated that the immunoreactive material detected in the CNS of rat actually corresponds to an active form of P-45011 (Ozaki et al., 1991). Recently, substantial amounts of P-45011 mRNA were detected in the neocortex and piriform cortex of the male rat by in situ hybridization, indicating that synthesis of corticosterone can occur in the CNS. Interestingly, the same regions of the brain which express the P-45011 gene also contain high concentrations of glucocorticoid receptors (Erdmann et al., 1996), suggesting a physiological role for brain-derived corticosterone in the neocortex.

	XII. Other Enzymes Involved in the Synthesis or Metabolism of Steroids

Top Previous Next References

Several other enzymatic activities involved in the synthesis or metabolism of steroid hormones have been evidenced in the CNS. However, the mapping of these enzymes in the brain has not yet been studied by immunocytochemistry, neither has the location of their mRNAs been investigated by in situ hybridization, so that the cellular distribution and the regulation of the expression of these enzymes remain unknown.

A. 3-Hydroxysteroid Dehydrogenase

The enzyme 3-HSD is a member of the aldo-keto reductase family, which is composed of various enzymes including aldehyde reductase, aldose reductase, and dihydrodiol dehydrogenase (Bohren et al., 1989; Penning, 1997). 3-HSD catalyzes the conversion of 5-DHT into 3-androstanediol and the conversion of 5-DHP into allopregnanolone (Fig. 7). The existence of multiple cDNAs encoding various proteins structurally related to 3-HSD has been reported in humans (Qin et al., 1993) but, to date, only two functional 3-HSD isoenzymes (type I 3-HSD and type II 3-HSD) have been characterized on the basis of their affinity for 5-DHT (Khanna et al., 1995a; Penning, 1997). In the rat, a 3-HSD cDNA has been cloned (Pawlowski et al., 1991) and the corresponding gene has now been fully characterized (Lin and Penning, 1995; Penning et al., 1996).

View larger version (29K): [in this window] [in a new window]   Fig. 7.   Current knowledge concerning the biochemical pathways of neurosteroidogenesis. Solid arrows indicate that the biochemical reaction has been formally demonstrated, i.e., both the biological activity of the enzyme in neural tissue and the localization of the enzyme by immunohistochemistry or its mRNAs in situ hybridization in the nervous system are documented. Dashed arrows indicate that only the biological activity of the enzyme is documented in the nervous system. Multiple arrows indicate that the occurrence of the enzyme has not yet been found in the nervous system.

In vitro and in vivo experiments have demonstrated the presence of 3-HSD bioactivity in the CNS of primates (Roselli et al., 1987; Clark et al., 1988; Bonsall et al., 1989, 1990) and rodents (Celotti et al., 1987, 1992; Krieger and Scott, 1989), indicating that 5-DHT and 5-DHP are metabolized in the brain (Martini et al., 1996). Intense 3-HSD activity has been found in the olfactory bulb, olfactory tubercle, thalamus, caudate nucleus, cerebral cortex, and hypothalamus (Krieger and Scott, 1984, 1989; Khanna et al., 1995a). Northern blot analysis has shown that type II 3-HSD is the predominant form in the human brain (Khanna et al., 1995b). In the rat, 3-HSD activity is expressed in type 1 astrocytes while neurons, oligodendrocytes, and type 2 astrocytes contain 5-R activity (Melcangi et al., 1993). The fact that the two interdependent 5-R and 3-HSD enzymatic activities are differently located indicates that some kind of coordination between neurons and glial cells must be necessary to ensure the metabolism of various sex steroids, particularly testosterone and progesterone.

B. ⁵-3-Hydroxysteroid Acyltransferase

The enzyme ⁵-3-hydroxysteroid acyltransferase (acyltransferase) catalyzes the saponification reaction which converts ⁵-3-hydroxysteroids into lipoidal derivatives or fatty acid esters of steroids. The existence of acyltransferase activity in peripheral steroidogenic organs, including the adrenal gland and corpus luteum, has long been demonstrated (Mellon-Nussbaum and Hochberg, 1980).

In vitro studies have shown that incubation of hypothalamus, amygdala, or olfactory bulb explants with [³H]⁵P or [³H]DHEA yields to the formation of fatty acid esters of [³H]⁵P and [³H]DHEA (Robel et al., 1987; Baulieu et al., 1987; Jo et al., 1989; Vourc'h et al., 1992). These observations indicate that acyltransferase bioactivity is present in various regions of the CNS. However, the cellular localization of this enzyme remains unknown.

C. 7-Hydroxylase

Hydroxylation of steroids on the C₇ position is catalyzed by 7-hydroxylase, an enzyme that is found in various tissues. In particular, it has been shown that incubation of a rat testicular microsomal fraction with radioactive testosterone or androstenedione yields to the formation of their respective 7-hydroxylated metabolite (Inano and Tamaoki, 1971). In the liver, 7-hydroxylase is responsible for the conversion of cholesterol into 7OH-cholesterol (Noshiro et al., 1989).

The existence of a 7-hydroxylase activity in the CNS has been inferred from the observation that rat brain microsomal preparations can convert 3-androstanediol into a 7-hydroxylated derivative (Warner et al., 1989). It should be noted however that the presence of endogenous 3-androstanediol has never been demonstrated in the rat brain. Subsequently, it has been shown that rat brain microsomes are capable of converting the neurosteroids ⁵P and DHEA into 7-hydroxy-⁵P and 7-hydroxy-DHEA, respectively (Akwa et al., 1992), confirming the existence of 7-hydroxylase bioactivity in the CNS of rodents. The cDNA encoding a new isoform of cytochrome P-450 has been recently cloned from rat and mouse hippocampal libraries; the corresponding protein exhibits 39% sequence identity with liver cholesterol 7-hydroxylase (Cyp7a) (Stapleton et al., 1995). The mRNAs encoding this 7-hydroxylase-related enzyme (Cyp7b) are primarily located in the CNS, particularly in the hippocampus, whereas the Cyp7a gene is mainly expressed in the liver (Jelinek et al., 1990; Noshiro and Okuda, 1990; Stapleton et al., 1995). The recombinant Cyp7b protein possesses a high affinity for DHEA and ⁵P that are respectively converted by this enzyme into 7-hydroxy-DHEA and 7-hydroxy-⁵P (Rose et al., 1997).

D. Cytochrome P-450-Aldosterone Synthase

The last step of the aldosterone biosynthesis pathway is catalyzed by an enzymatic complex called cytochrome P-450-aldosterone synthase (P-450aldo) which exerts three distinct activities (11-hydroxylation, 18-hydroxylation, and 18-oxidoreduction) responsible for the conversion of 11-deoxycorticosterone successively into corticosterone, 18-hydroxycorticosterone, and aldosterone (Fig. 1). In the rat adrenal cortex, P-450aldo is exclusively located in the two or three outermost cell layers of the zona glomerulosa, whereas P-45011 is only present in the zona fasciculata reticularis (see section XI). The occurrence of P-450aldo activity has been reported in various tissues including the aortic endothelium, vascular smooth muscles, and myocardial tissue (Hatakeyama et al., 1994; Silvestre et al., 1998).

The initial investigations aimed at demonstrating the existence of P-450aldo in the CNS, using ribonuclease protection assays, were unsuccessful (Mellon and Deschepper, 1993). In contrast, these studies have identified the mRNAs encoding for P-450c₁₁ in various areas of the rat brain, namely, in the amygdala, cortex, cerebellum, and hippocampus. Recently, Gomez-Sanchez et al. (1997) have demonstrated by RT-PCR/Southern blot analysis the presence of P-450aldo in various regions of the CNS of the rat, including the hypothalamus, hippocampus, amygdala, and cerebellum. These authors have also shown that hippocampic, hypothalamic and cerebellar explants are capable of converting [³H]11-deoxycorticosterone into [³H]corticosterone, [³H]18-hydroxycorticosterone, and [³H]aldosterone. It thus appears that the enzyme detected in the rat brain is a biologically active form of P-450aldo.

	XIII. Conclusion and Clinical Implications

Top Previous Next References

Neuroanatomical and biochemical studies have now firmly established that several key enzymes of steroidogenesis such as P-450scc, 3-HSD, cytochrome P-450c₁₇, 17-HSD, 5-R, and aromatase are present in the brain of vertebrates (Fig. 7). The occurrence of sulfotransferase and sulfatase which catalyze the formation and deconjugation of sulfated esters of steroids, respectively, has also been demonstrated (Fig. 7). The cellular localization of these enzymes indicates that various types of nerve cells, either neurons or glial cells or both, participate in the biosynthesis of unconjugated and sulfated neurosteroids. Other enzymatic activities involved in the synthesis or metabolism of steroid hormones, such as 3-HSD, acyltransferase, 7-hydroxylase, and P-450aldo have also been detected in the CNS (Fig. 7) but the anatomical distribution of these enzymes remains to be determined.

To date, little is known concerning the involvement of steroidogenic enzymes expressed by nerve cells in the physiopathology of the nervous system. Therefore, the possible pharmacological implications are currently a matter of speculation. The decrease in the concentration of ⁵PS in the rat hippocampus during aging (Robel et al., 1995) suggests the existence of a correlation between the levels of sulfated neurosteroids and neurodegenerative processes. A promising therapeutic application would be to compensate the decline of the DHEAS level in aging subjects by administering moderate amounts of DHEA, a lipophilic substrate of HST which can easily cross the blood-brain barrier to be converted, in the CNS, into DHEAS (Baulieu and Robel, 1996, 1998). Another pharmacological approach would be to develop novel psychotropic agents which may selectively control, in nerve cells, the expression and/or activity of enzymes involved in the biosynthesis of potent neuroactive neurosteroids such as allopregnanolone, DHEA, ⁵P, and their sulfated derivatives.

Neurosteroids, which are involved in the regulation of stress responses, anxiety, sleep, neurodegenerative processes, aggressive behavior, and cognitive activities, are now considered as key factors of chemical neurotransmission. Because most of the biochemical pathways of neurosteroidogenesis are now elucidated (Fig. 7), the main questions which have to be answered during the next years concern the role of classical neurotransmitters and neuropeptides in the control of the expression of steroidogenic enzyme genes and activities in the brain.

	XIV. Summary

Top Previous Next References

Steroid hormones exert important functions in the control of growth, maturation, and differentiation of the central and peripheral nervous systems. These actions have long been attributed exclusively to steroid hormones secreted by endocrine glands, i.e., adrenal, ovary, and testis. However, during the last decade, it has been shown that nerve cells (both neurons and glial cells) are capable of synthesizing bioactive steroids, now called neurosteroids, which also participate in the control of various functions in the CNS. One of the major criteria supporting the concept of neurosteroidogenesis is based on the occurrence of steroidogenic enzymes in nerve cells. Immunocytochemical and in situ hybridization techniques have made it possible to determine the neuroanatomical distribution of key enzymes such as P-450scc, 3-HSD, cytochrome P-450c₁₇, 17-HSD, 5-R, aromatase, sulfotransferase, and sulfatase. Concurrently, the presence of enzymatic activities for steroid biosynthesis has been demonstrated in neurons and/or glial cells, thus indicating that the isozymes expressed in nerve cells actually correspond to active forms of the steroidogenic enzymes. Recent studies concerning the control of the expression and activity of key steroidogenic enzymes in the CNS strongly suggest that neurosteroidogenesis may be regulated by adrenal and gonadal steroids as well as by neuropeptides of the endozepine family.

	Acknowledgments

Top Previous Next References

This work was supported by grants from the Institut National de la Santé and de la Recherche Médicale (U 413), The Ministère des Affaires Etrangères (France-Québec exchange program to G.P. and H.V.), and the Conseil Régional de HauteNormandie. J.L.D.R. was a recipient of a fellowship from AGEFIPH. D.B. was a recipient of a fellowship from the Ministère de l'Education Nationale, de l'Enseignement Supérieur and de la Recherche.

	Footnotes

¹ Address for correspondence: Dr. Hubert Vaudry, European Institute for Peptide Research (IFRMP no. 23), Laboratory of Cellular and Molecular Neuroendocrinology, INSERM U 413, UA CNRS, University of Rouen, 76821 Mont-Saint-Aignan, France. E-mail: hubert.vaudry{at}univ-rouen.fr

	Abbreviations

CNS, central nervous system; GABA_A, type A -aminobutyric acid receptors; NMDA, N-methyl-D-aspartate receptors; DBI, diazepam-binding inhibitor; DHEA, dehydroepiandrosterone; ⁵P, pregnenolone; DHEAS, dehydroepiandrosterone sulfate; ⁵PS, pregnenolone sulfate; ODN, octadecaneuropeptide (DBI[33-50]); PAPS, 3'-phosphoadenosine,5'-phosphosulfate; PBR, peripheral-type benzodiazepine receptor; PK11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methyl-propyl)-3-isoquinoline carboxamide; PNS, peripheral nervous system; TTN, triakontatetraneuropeptide (DBI[17-50]); P-450scc, cytochrome P-450 side chain cleavage; P450c₁₇, cytochrome P-450c₁₇; P-45011, cytochrome P-45011; P-450aldo, cytochrome P-450-aldosterone synthase; 3-HSD, 3-hydroxysteroid dehydrogenase; 3-HSD, 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase; HST, hydroxysteroid sulfotransferase; 5-R, 5-reductase; 5-DHT, 5-dihydrotestosterone; 11-HSD, 11-hydroxysteroid dehydrogenase; 17-HSD, 17-hydroxysteroid dehydrogenase.

	References

Top Previous

• Abbaszade IG, Arensburg J, Park CH, Kasa-Vubu JZ, Orly J and Payne AH (1997) Isolation of a new mouse 3-hydroxysteroid dehydrogenase isoform, 3-HSD VI, expressed during early pregnancy. Endocrinology  138: 1392-1399[Abstract/Free Full Text].
• Abdelgadir SE, Resko JA, Ojeda SR, Lephart ED, McPhaul MJ and Roselli CE (1994) Androgens regulate aromatase cytochrome P-450 messenger ribonucleic acid in rat brain. Endocrinology  135: 395-401[Abstract].
• Abe-Dohmae S, Tanaka R and Harada N (1994) Cell-type and region-specific expression of aromatase mRNA in cultured brain cells. Mol Brain Res  24: 153-158[Medline].
• Adamski J, Husen B, Marks F and Jungblut PW (1992) Purification and properties of estradiol 17-dehydrogenase extracted from cytoplasmic vesicles of porcine endometrial cells. Biochem J  288: 375-381.
• Adamski J, Normand T, Leenders F, Monte D, Begue A, Stehelin D, Jungblut PW and de Launoit Y (1995) Molecular cloning of a novel, widely expressed human 80 kDa 17-hydroxysteroid dehydrogenase IV. Biochem J  311: 437-443.
• Agarwal AK, Monder C, Eckstein B and White PC (1989) Cloning and expression of rat cDNA encoding corticosteroid 11-dehydrogenase. J Biol Chem  264: 18939-18943[Abstract/Free Full Text].
• Agarwal AK, Mune T, Monder C and White PC (1994) NAD⁺-dependent isoform of 11-hydroxysteroid dehydrogenase: cloning and characterization of cDNA from sheep kidney. J Biol Chem  269: 25959-25962[Abstract/Free Full Text].
• Akwa Y, Morfin RF, Robel P and Baulieu EE (1992) Neurosteroid metabolism: 7-hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem J  288: 959-964.
• Albers HE, Hennessey AC and Whitman DC (1992) Vasopressin and the regulation of hamster social behavior. Ann NY Acad Sci  652: 227-242[Medline].
• Albiston AL, Obeyesekere VR, Smith RE and Krozowski KS (1994) Cloning and tissue distribution of the human 11-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol  105: R11-R17[Medline].
• Alho H, Varga V and Krueger KE (1994) Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: Relation to cell growth. Cell Growth & Differ  5: 1005-1014[Abstract].
• Andersen AC, Tonon MC, Pelletier G, Conlon JM, Fasolo A and Vaudry H (1992) Neuropeptides in the amphibian brain. Int Rev Cytol  138: 89-210[Medline].
• Andersson S (1995) 17-hydroxysteroid dehydrogenase: isozymes and mutations. J Endocrinol  146: 241-251.
• Andersson S, Berman DM, Jenkins EP and Russell DW (1991) Deletion of steroid 5-R 2 gene in male pseudohermaphroditism. Nature (London)  354: 159-161[Medline].
• Andersson S and Moghrabi N (1997) Physiology and molecular genetics of 17-hydroxysteroid dehydrogenases. Steroids  62: 143-147[Medline].
• Andersson S and Russell DW (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5-reductases. Proc Natl Acad Sci USA  87: 3640-3644[Abstract/Free Full Text].
• Arnold AP and Gorski RA (1984) Gonadal steroid induction of structural sex differences in the central nervous system. Annu Rev Neurosci  7: 413-442[Medline].
• Aziz N, Brown D, Lee WS and Naray-Fejes-Toth A (1996) Aberrant 11-hydroxysteroid dehydrogenase-1 activity in the cpk mouse: implications for regulation by the Ke 6 gene. Endocrinology  137: 5581-5588[Abstract].
• Baillien M and Balthazart J (1997) A direct dopaminergic control of aromatase activity in the quail preoptic area. J Steroid Biochem Mol Biol  63: 99-113[Medline].
• Ballabio A and Shapiro LJ (1995) Steroid sulfatase deficiency and X-linked ichthyosis, in The Metabolic and Molecular Bases of Inherited Disease (Schriver CR, Beaudet AL, Sly WS andValle D eds) pp 2999-3022, McGraw-Hill, New York.
• Balthazart J, Foidart A and Harada N (1990a) Immunocytochemical localization of aromatase in the brain. Brain Res  514: 327-333[Medline].
• Balthazart J, Foidart A, Surlemont C and Harada N (1991a) Distribution of aromatase-immunoreactive cells in the mouse forebrain. Cell Tissue Res  263: 71-79[Medline].
• Balthazart J, Foidart A, Surlemont C and Harada N (1991b) Neuroanatomical specificity in the co-localization of aromatase and estrogen receptors. J Neurobiol  22: 143-157[Medline].
• Balthazart J, Foidart A, Surlemont C, Harada N and Naftolin F (1992) Neuroanatomical specificity in the autoregulation of aromatase-immunoreactive neurons by androgens and estrogens: an immunocytochemical study. Brain Res  574: 280-290[Medline].
• Balthazart J, Foidart A, Surlemont C, Vockel A and Harada N (1990b) Distribution of aromatase in the brain of the Japanese quail, ring dove, and zebra finch: an immunocytochemical study. J Comp Neurol  301: 276-288[Medline].
• Balthazart J, Gahr M and Surlemont C (1989) Distribution of estrogen receptors in the brain Japanese quail: An immunocytochemical study. Brain Res  501: 205-214[Medline].
• Bartsch W, Klein H, Schiemann U, Bauer HW and Voigt KD (1990) Enzymes of androgen formation and degradation in the human prostate. Ann NY Acad Sci  595: 53-66[Medline].
• Bauer HC and Bauer H (1989) Micromethod for the determination of 3-HSD activity in cultured cells. J Steroid Biochem  33: 643-646[Medline].
• Baulieu EE (1981) Steroid hormones in the brain: Several mechanisms?, in Steroid Hormone Regulation of the Brain (Fuxe K, Gutafsson JA andWetterberg L eds) pp 3-14, Pergamon Press, Oxford.
• Baulieu EE and Robel P (1990) Neurosteroids: A new brain function? J Steroid Biochem Mol Biol  37: 395-403[Medline].
• Baulieu EE and Robel P (1996) Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids. J Endocrinol  150: S221-S239[Medline].
• Baulieu EE and Robel P (1998) Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc Natl Acad Sci USA  95: 4089-4091[Free Full Text].
• Baulieu EE, Robel P, Vatier O, Haug M, Le Goascogne C and Bourreau E (1987) Neurosteroids: Pregnenolone and dehydroepiandrosterone in the brain, in Receptor-Receptor Interactions (Fuxe K andAgnati LF eds) vol 48, pp 89-104, MacMillan Press, Basingstoke.
• Baulieu EE, Schumacher M, Koenig H, Jung-Testas I and Akwa Y (1996) Progesterone as a neurosteroid: actions within the nervous system. Cell Mol Neurobiol  16: 143-153[Medline].
• Beaujean D, Mensah-Nyagan AG, Do-Régo JL, Luu-The V, Pelletier G and Vaudry H (1999) Immunocytochemical localization and biological activity of hydroxysteroid sulfotransferase in the frog brain. J Neurochem  72: 848-857[Medline].
• Bélanger B, Bélanger A, Labrie F, Dupont A, Cusan L and Monfette G (1989) Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: Unique importance of extratesticular androgens in men. J Steroid Biochem  32: 695-698[Medline].
• Benavides JJ, Guilloux F, Allan DE, Uzan A, Mizoule J, Renault C, Guérémy C and Le Fur G (1984) Opposite effects of antagonist, PK11195, of the peripheral benzodiazepine binding sites on audiogenic seizure in DBA/2J mice. Life Sci  34: 2613-2620[Medline].
• Berman DM and Russell DW (1993) Cell-type-specific expression of rat 5-reductase isozymes. Proc Natl Acad Sci USA  90: 9359-9363[Abstract/Free Full Text].
• Beyer C, Green SJ, Baker PJ, Huskisson NS and Hutchison JB (1994a) Aromatase-immunoreactivity is localized in neurons in the developing mouse hypothalamus and cortex. Brain Res  638: 203-210[Medline].
• Beyer C, Green SJ and Hutchison JB (1994b) Androgens influence sexual differentiation of embryonic mouse hypothalamic aromatase neurons in vitro. Endocrinology  135: 1220-1226[Abstract].
• Beyer C, Tramonte R and Hutchison JB (1994c) Aromatase-immunoreactive neurons in the adult female chicken brain detected using a specific antibody. Brain Res Bull  33: 583-588[Medline].
• Biswas MG and Russell (1997) Expression cloning and characterization of oxidative 17- and 3-hydroxysteroid dehydrogenases from rat and human prostate. J Biol Chem  272: 15959-15966[Abstract/Free Full Text].
• Blomquist CH (1995) Kinetic analysis of enzymatic activities: prediction of multiple forms of 17-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol  55: 515-524[Medline].
• Bohren KM, Bullock B, Wermuth B and Gabbay KH (1989) The aldoketo reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem  264: 9547-9551[Abstract/Free Full Text].
• Bonsall RW, Rees HD and Michael RP (1989) Identification of radioactivity in cell nuclei from brain, pituitary gland and genital tract of male rhesus monkeys after the administration of [³H]testosterone. J Steroid Biochem  32: 599-608[Medline].
• Bonsall RW, Zumpe D and Michael RP (1990) Comparison of the nuclear uptake of [³H]-testosterone and its metabolites by brains of male and female macaque fetuses at 122 days of gestation. Neuroendocrinology  51: 474-480[Medline].
• Brodgen RN and Goa KL (1991) Flumazenil: A reappraisal of its pharmacological properties and therapeutic efficacity as benzodiazepine antagonist. Drugs  42: 1061-1089[Medline].
• Brown AS, Hall PF, Shoyab M and Papadopoulos V (1992) Endozepine/diazepam binding inhibitor in adrenocortical and Leydig cell lines: Absence of hormonal regulation. Mol Cell Endocrinol  83: 1-9[Medline].
• Brown RW, Chapman KE, Edwards CRW and Seckl JR (1993) Human placental 11-hydroxysteroid dehydrogenase: Partial purification of and evidence for a distinct NAD-dependent isoform. Endocrinology  132: 2641-2621.
• Brown RW, Kotolevtsev Y, Leckie C, Lindsay RS, Lyons V, Murad P, Mullins JJ, Chapman KE, Edwards CRW and Seckl JR (1996) Isolation and cloning of human placental 11-hydroxysteroid dehydrogenase-2 cDNA. Biochem J  313: 1007-1017.
• Burgos-Trinidad M, Youngblood GL, Maroto MR, Scheller A, Robins DM and Payne AH (1997) Repression of cAMP-induced expression of the mouse P-450 17-hydroxylase/C17-20 lyase gene (Cyp17) by androgens. Mol Endocrinol  11: 87-96[Abstract/Free Full Text].
• Callard CV, Petro Z and Ryan KJ (1980) Aromatization of androgen to estrogen by cultured turtle brain. Brain Res  202: 117-130[Medline].
• Casey ML, MacDonald PC and Andersson S (1994) 17-hydroxysteroid dehydrogenase type 2: Chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest  94: 2135-2141.
• Celotti F, Melcangi R and Martini L (1992) The 5alpha-reductase in the brain: Molecular aspects and relation to brain function. Front Neuroendocrinol  13: 163-215[Medline].
• Celotti F, Melcangi R, Negri-Cesi P, Ballabio M and Martini L (1987) Differential distribution of the 5-reductase in the central nervous system of the rat and the mouse: Are the white matter structures of the brain target tissues for testosterone action? J Steroid Biochem  26: 125-129[Medline].
• Celotti F, Negri-Cesi P, Limonta P and Melcangi C (1983) Is the 5alpha-reductase of the hypothalamus and of the anterior pituitary neurally regulated? Effects of hypothalamic deafferentations and of centrally acting drugs. J Steroid Biochem  19: 229-234[Medline].
• Cheng CY, Flasch MV and Hornsby PJ (1992) Expression of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase in fetal human adrenocortical cells transfected with SV40 antigen. J Mol Endocrinol  9: 7-17[Abstract/Free Full Text].
• Clark AS, MacLusky NJ and Goldman-Rakic PS (1988) Androgen binding and metabolism in the cerebral cortex of the developing rhesus monkey. Endocrinology  123: 932-940[Abstract/Free Full Text].
• Clemens JW, Lala DS, Parker KL and Richards JS (1994) Steroidogenic factor-1 binding and transcriptional activity of the cholesterol side-chain cleavage promoter in rat granulosa cells. Endocrinology  134: 1499-1508[Abstract/Free Full Text].
• Cole TJ (1995) Cloning of a mouse 11 beta-hydroxysteroid dehydrogenase type 2: Tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney. Endocrinology  136: 4693-4696[Abstract].
• Compagnone NA, Bulfone A, Rubenstein JLR and Mellon S (1995a) Expression of the steroidogenic enzyme cytochrome P450scc in the central and peripheral nervous systems during rodent embryogenesis. Endocrinology  136: 2689-2696[Abstract].
• Compagnone NA, Bulfone A, Rubenstein JLR and Mellon S (1995b) Steroidogenic enzyme P450c17 is expressed in the embryonic central nervous system. Endocrinology  136: 5212-5223[Abstract].
• Compagnone NA, Salido E, Shapiro LJ and Mellon SH (1997) Expression of steroid sulfatase during embryogenesis. Endocrinology  138: 4768-4773[Abstract/Free Full Text].
• Conley AJ, Corbin CJ, Smith T, Hinshelwood M, Liu Z and Simpson E (1997) Porcine aromatases: Studies on tissue-specific, functionally distinct isozymes from a single gene? J Steroid Biochem Mol Biol  61: 407-413[Medline].
• Corbin CJ, Graham-Lorence S, McPhaul M, Mason JL, Mendelson CR and Simpson ER (1988) Isolation of a full length cDNA insert encoding human aromatase system cytochrome P-450 and its expression in non-steroidogenic cells. Proc Natl Acad Sci USA  85: 8948-8952[Abstract/Free Full Text].
• Corbin CJ, Khalil MW and Conley AJ (1995) Functional ovarian and placental isoforms of porcine aromatase. Mol Cell Endocrinol  113: 29-37[Medline].
• Corpéchot C, Robel P, Axelsön M, Sjövall J and Baulieu EE (1981) Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA  78: 4704-4707[Abstract/Free Full Text].
• Corpéchot C, Synguelakis M, Talha S, Axelsön M, Sjövall J, Vihko R, Baulieu EE and Robel P (1983) Pregnenolone and its ester sulfate in the rat brain. Brain Res  270: 119-123[Medline].
• Costa E, Auta J, Guidotti A, Korneyev A and Romeo E (1994) The pharmacology of neurosteroidogenesis. J Steroid Biochem Mol Biol  49: 385-389[Medline].
• De Vries GJ (1990) Sex differences in neurotransmitter systems. J Neuroendocrinol  2: 1-13.
• Do-Régo JL, Mensah-Nyagan AG, Feuilloley M, Ferrara P, Pelletier G and Vaudry H (1998) The endozepine triakontatetraneuropeptide diazepam-binding inhibitor [17-50] stimulates neurosteroid biosynthesis in the frog hypothalamus. Neuroscience  83: 555-570[Medline].
• Duan WR, Linzer DIH and Gibori G (1996) Cloning and characterization of an ovarian-specific protein that associates with the short form of the prolactin receptor. J Biol Chem  271: 15602-15607[Abstract/Free Full Text].
• Duan WR, Parmer TG, Albarracin CT, Zhong L and Gibori G (1997) PRAP, a prolactin receptor associated protein: Its gene expression and regulation in the corpus luteum. Endocrinology  138: 3216-3221[Abstract/Free Full Text].
• Dumont M, Luu-The V, Dupont E, Pelletier G and Labrie F (1992) Characterization, expression and immunohistochemical localization of 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase in human skin. J Invest Dermatol  99: 415-427[Medline].
• Duperrex H, Kenouch S, Gaeggeler HP, Seckl JR, Edwards CRW, Farman N and Rossier BC (1993) Rat liver 11-hydroxysteroid dehydrogenase cDNA encodes oxoreductase activity in a mineralocorticoid-responsive toad bladder cell line. Endocrinology  132: 612-619[Abstract/Free Full Text].
• Dupont E, Luu-The V, Labrie F and Pelletier G (1990a) Ontogeny of 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase (3-HSD) in human adrenal gland performed by immunocytochemistry. Mol Cell Endocrinol  74: R7-R10[Medline].
• Dupont E, Luu-The V, Labrie F and Pelletier G (1990b) Light microscopic immunocytochemical localization of 3-hydroxy-5-ene-steroid dehydrogenase/⁵-⁴-isomerase in the gonads and adrenal glands of the guinea pig. Endocrinology  126: 2906-2909[Abstract/Free Full Text].
• Dupont E, Simard J, Luu-The V, Labrie F and Pelletier G (1994) Localization of 3-hydroxysteroid dehydrogenase in rat brain as studied by in situ hybridization. Mol Cell Neurosci  5: 119-123[Medline].
• Dupont E, Zhao HF, Rhéaume E, Simard J, Luu-The V, Labrie F and Pelletier G (1990c) Localization of 3-hydroxy-5-ene steroid dehydrogenase/⁵-⁴ isomerase in the rat gonads and adrenal glands by immunocytochemistry and in situ hybridization. Endocrinology  127: 1394-1403[Abstract/Free Full Text].
• Edwards CRM, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER and Monder C (1988) Localisation of 11-hydroxysteroid dehydrogenase- tissue specific protector of the mineralocorticoid receptor. Lancet  2: 986-989[Medline].
• Ehrhart-Bornstein M, Bornstein SR, Trzeciak WH, Usadel H, Güse-Behling H, Waterman MR and Scherbaum WA (1991) Adrenaline stimulates cholesterol side chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. J Endocrinol  131: R5-R8[Abstract/Free Full Text].
• Erdmann B, Gerst H, Bülow H, Lenz D, Bähr V and Bernhardt R (1995) Zone-specific localization of cytochrome P45011B1 in human adrenal tissue by PCR-derived riboprobes. Histochem Cell Biol  104: 301-307[Medline].
• Erdmann B, Gerst H, Lippoldt A, Bülow H, Ganten D, Fuxe K and Bernhardt R (1996) Expression of cytochrome P45011B1 mRNA in the brain of normal and hypertensive transgenic rats. Brain Res  733: 73-82[Medline].
• Ferrero P, Santi MR, Conti-Tronconi B, Costa E and Guidotti A (1986) Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): Biological activity and presence in rat brain. Proc Natl Acad Sci USA  83: 827-831[Abstract/Free Full Text].
• Ffrench-Müllen JMH, Danks P and Spence KT (1994) Neurosteroids modulate calcium currents in hippocampal CA1 neurons via a pertussis toxin-sensitive G-protein-coupled mechanism. J Neurosci  14: 1963-1977[Abstract].
• Ffrench-Müllen JMH and Spence KT (1991) Neurosteroids block Ca²⁺ channel currents in freshly isolated hippocampal CA1 neurons. Eur J Pharmacol  202: 269-272[Medline].
• Foidart A, Harada N and Balthazart J (1995) Aromatase-immunoreactive cells are present in the mouse brain areas that are known to express high levels of aromatase activity. Cell Tissue Res  280: 561-574[Medline].
• Fomitcheva J, Baker ME, Anderson E, Lee GY and Aziz N (1998) Characterization of Ke 6, a new 17-hydroxysteroid dehydrogenase, and its expression in gonadal tissues. J Biol Chem  273: 22664-22671[Abstract/Free Full Text].
• Fournet-Dulguerov N, MacLusky NJ, Leranth CZ, Todd R, Mendelson CR, Simpson ER and Naftolin F (1987) Immunocytochemical localization of aromatase cytochrome P450 and estradiol in the syncytiotrophoblast of the human placenta. J Clin Endocrinol Metab  65: 757-764[Abstract/Free Full Text].
• Fritz IB, Griswold MD, Louis BF and Dorrington JH (1976) Similarity of responses of cultured Sertoli cells to cholera toxin and FSH. Mol Cell Endocrinol  5: 294-298.
• Geissler WM, Davis DL, Wu L, Bradshaw KD, Sushma P, Mendonca BB, Elliston KO, Wilson JD, Russell DW and Andersson S (1994) Male pseudohermaphroditism caused by mutations of testicular 17-hydroxysteroid dehydrogenase 3. Nature (London)  7: 34-39.
• Ghersevich S, Nokelainen P, Poutanen M, Orova M, Autio-Harmainen H, Rajaniemi H and Vihko R (1994) Rat 17-hydroxysteroid dehydrogenase type 1: Primary structure and regulation of enzyme expression in rat ovary by diethylstilbestrol and gonadotropins in vivo. Endocrinology  135: 1477-1487[Abstract].
• Gomez-Sanchez CE, Zhou MY, Cozza EN, Morita H, Foecking MF and Gomez-Sanchez EP (1997) Aldosterone biosynthesis in the rat brain. Endocrinology  138: 3369-3373[Abstract/Free Full Text].
• Grazzini E, Guillon G, Mouillac B and Zingg HH (1998) Inhibition of oxytocin receptor function by direct binding of progesterone. Nature (London)  392: 509-512[Medline].
• Green PS, Bishop J and Simpkins JW (1997) 17-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci  17: 511-515[Abstract/Free Full Text].
• Grosser BI and Axelrod LR (1968) Conversion of cortisol to cortisol acetate, cortisone acetate and cortisone by the developing primate brain. Steroids  11: 827-836[Medline].
• Guarneri P, Papadopoulos V, Pan B and Costa E (1992) Regulation of pregnenolone synthesis in C6B glioma cells by 4'-chlorodiazepam. Proc Natl Acad Sci USA  89: 5118-5122[Abstract/Free Full Text].
• Guennoun R, Fiddes RJ, Gouézou M, Lombes M and Baulieu EE (1995) A key enzyme in the biosynthesis of neurosteroids, 3-hydroxysteroid dehydrogenase/⁵-⁴-isomerase (3-HSD), is expressed in rat brain. Mol Brain Res  30: 287-300[Medline].
• Guennoun R, Schumacher M, Robert F, Delespierre B, Gouézou M, Eychenne B, Akwa Y, Robel P and Baulieu EE (1997) Neurosteroids: Expression of functional 3-hydroxysteroid dehydrogenase by rat sensory neurons and Schwann cells. Eur J Neurosci  9: 2236-2247[Medline].
• Guérin SL, Leclerc S, Verreault H, Labrie F and Luu-The V (1995) Overlapping cis-acting elements located in the first intron of the gene for type I 3-hydroxysteroid dehydrogenase modulates its transcriptional activity. Mol Endocrinol  9: 1583-1597[Abstract/Free Full Text].
• Güse-Behling H, Ehrhart-Bornstein M, Bornstein SR, Waterman MR, Scherbaum WA and Adler G (1992) Regulation of adrenal steroidogenesis by adrenaline: Expression of cytochrome P450 genes. J Endocrinol  135: 229-237[Abstract/Free Full Text].
• Haidan A, Bornstein SR, Glasow A, Uhlmann K, Lübke C and Ehrhart-Bornstein M (1998) Basal steroidogenic activity of adrenocortical cells is increased 10-fold by coculture with chromaffin cells. Endocrinology  139: 772-780[Abstract/Free Full Text].
• Harada N (1988) Cloning of a comparative cDNA encoding human aromatase: immunochemical identification and sequence analysis. Biochem Biophys Res Commun  156: 725-732[Medline].
• Harada N, Yamada K, Foidart A and Balthazart J (1992) Regulation of aromatase cytochrome P-450 (estrogen synthetase) transcripts in the quail brain by testosterone. Mol Brain Res  15: 19-26[Medline].
• Harada N, Yamada K, Saitoh K, Kibe N, Dohmae S and Takagi Y (1990) Structural characterization of the human estrogen synthetase (aromatase) gene. Biochem Biophys Res Commun  166: 365-372[Medline].
• Hatakeyama H, Miyamori I, Fujita T, Takeda R and Yamamoto H (1994) Vascular androsterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem  269: 24316-24320[Abstract/Free Full Text].
• Hickey GT, Krasnow JS, Beattie WG and Richards JS (1990) Aromatase cytochrome P450 in rat ovarian granulosa cells before and after luteinization: Adenosine 3,5-monophosphate-dependent and independent regulation. Cloning and sequencing of rat aromatase cDNA and 5 genomic DNA. Mol Endocrinol  4: 3-12[Abstract/Free Full Text].
• Hinshelwood MM, Corbin CJ, Tsang PCW and Simpson ER (1993) Isolation and characterization of a cDNA insert encoding bovine aromatase cytochrome P450. Endocrinology  133: 1971-1977[Abstract/Free Full Text].
• Ho MM and Vinson GP (1993) 11-hydroxylase gene expression in the rat adrenal cortex. J Endocrinol  139: 301-306[Abstract/Free Full Text].
• Ikeda Y, Shen WH, Ingraham HA and Parker KL (1994) Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol  8: 654-662[Abstract/Free Full Text].
• Inano H and Tamaoki BI (1971) Regulation of testosterone biosynthesis in rat testis by 7-hydroxylated C19-steroids. Biochim Biophys Acta  239: 482-493[Medline].
• Iwamori M, Moser HW and Kishimoto Y (1976) Steroid sulfate in brain: Comparison of sulfohydroxylase activities for various steroid sulfates in normal and pathological brains, including the various forms of metachromatic leukodystrophy. J Neurochem  27: 1389-1395[Medline].
• Jakab RL, Harada N and Naftolin F (1994) Aromatase -(estrogen synthetase)-immunoreactive neurons in the rat septal area. A light and electron microscopic study. Brain Res  664: 85-93[Medline].
• Jakab RL, Horvath TL, Leranth C, Harada N and Naftolin F (1993) Aromatase immunoreactivity in the rat brain: Gonadectomy-sensitive neurons and unresponsive "limbic ring" of the lateral septum-bed nucleus-amygdala complex. J Steroid Biochem Mol Biol  44: 481-498[Medline].
• Jantus-Lewintre E, Orava M and Vihko R (1994) Regulation of 17-hydroxysteroid dehydrogenase type 1 by epidermal growth factor and transforming growth factor alpha in choriocarcinoma cells. Endocrinology  135: 2624-2629.
• Jelinek DF, Andersson S, Slaughter CA and Russel DW (1990) Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem  265: 8190-8197[Abstract/Free Full Text].
• Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD and Russell DW (1992) Genetic and pharmacological evidence for more than one human steroid 5-reductase. J Clin Invest  89: 293-300.
• Jo DH, Abdallah MA, Young J, Baulieu EE and Robel P (1989) Pregnenolone, dehydroepiandrosterone and their sulfate and fatty acid esters in the rat brain. Steroids  54: 287-297[Medline].
• Jones KJ (1993) Gonadal steroids and neuronal regeneration. A therapeutic role. Adv Neurol  59: 227-297[Medline].
• Jung-Testas I, Hu ZY, Baulieu EE and Robel P (1989) Neurosteroids: Biosynthesis of pregnenolone and progesterone in primary cultures of rat glial cells. Endocrinology  125: 2083-2091[Abstract/Free Full Text].
• Kabbadj K, El-Etr M, Baulieu EE and Robel P (1993) Pregnenolone metabolism in rodent embryonic neurons and astrocytes. Glia  7: 170-175[Medline].
• Kalra SP, Sahu A, Kalra PS and Crowley WR (1990) Hypothalamic neuropeptide Y: A circuit in the regulation of gonadotropin secretion and feeding behavior. Ann NY Acad Sci  611: 273-283[Medline].
• Kawata M, McCabe JT, Chung SK, Dutt A, Yuri K, Hirakawa M, Kumamoto K, Hirayama Y and Pfaff DW (1991) The effect of progesterone on oxytocin messenger RNA in hypothalamic neurons of estrogen-treated female rats studied with quantitative in situ hydridization histochemistry. Biomed Res  12: 405-415.
• Khanna M, Qin KN and Cheng KC (1995a) Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans. J Steroid Biochem Mol Biol  53: 41-46[Medline].
• Khanna M, Qin KN, Wang RW and Cheng KC (1995b) Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3-hydroxysteroid dehydrogenases. J Biol Chem  270: 20162-20168[Abstract/Free Full Text].
• Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV and Herbert J (1998) Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci USA  95: 1852-1857[Abstract/Free Full Text].
• King JA and Millar RP (1992) Evolution of gonadotropin-releasing hormones. Trends Endocrinol Metab  9: 339-346.
• Kishimoto Y and Sostek R (1972) Activity of sterol-sulphate sulphohydroxylase in rat brain: Characterization, localization and change with age. J Neurochem  19: 123-130[Medline].
• Klangkalya B and Chan A (1988) Structure-activity relationships of steroid hormones on muscarinic receptor binding. J Steroid Biochem  29: 111-118[Medline].
• Knapstein P, David A, Wu C, Archer DF, Flickinger GL and Touchstone JC (1968) Metabolism of free and sulfoconjugated DHEA in brain tissue in vivo and in vitro. Steroids  11: 885-896[Medline].
• Korneyev A, Pan BS, Polo A, Romeo E and Costa E (1993) Stimulation of brain pregnenolone synthesis by mitochondrial diazepam-binding inhibitor receptor ligands in vivo. J Neurochem  61: 1515-1524[Medline].
• Krieger NR and Scott RG (1984) 3-Hydroxysteroid oxidoreductase in rat brain. J Neurochem  42: 887-890[Medline].
• Krieger NR and Scott RG (1989) Nonneuronal localization for steroid converting enzyme 3-hydroxysteroid oxidoreductase in olfactory tubercle of rat brain. J Neurochem  52: 1866-1870[Medline].
• Krueger KE and Papadopoulos V (1990) Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membrane in adrenocortical cells. J Biol Chem  265: 15015-15022[Abstract/Free Full Text].
• Labrie F, Luu-The V, Lin SX, Labrie C, Simard J, Breton R and Bélanger A (1997) The key role of 17-hydroxysteroid dehydrogenases in sex steroid biology. Steroids  62: 148-158[Medline].
• Labrie F, Simard J, Luu-The V, Pelletier G and Bélanger A (1992) Cloning, expression and regulation of tissue-specific expression of 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase, in Cellular and Molecular Biology of the Adrenal Cortex (Saez JM, Brownie AC, Capponi EM, Chambaz E andMantero F eds) vol 222, pp 89-109, INSERM/J Libbey, London.
• Labrie F, Simard J, Luu-The V, Pelletier G, Belghmi K and Bélanger A (1994) Structure, regulation and role of 3-hydroxysteroid dehydrogenase, 17-hydroxysteroid dehydrogenase and aromatase enzymes in the formation of sex steroids in classical and peripheral intracrine tissues. Bailière's Clin Endocrinol Metab  8: 451-474[Medline].
• Lachance Y, Luu-The V, Verreault H, Dumont M, Rhéaume E, Leblanc G and Labrie F (1991) Structure of the human type II 3-hydroxysteroid dehydrogenase/⁵-⁴-isomerase (3-HSD) gene: adrenal and gonadal specificity. DNA Cell Biol  10: 701-711[Medline].
• Lakshmi V, Sakai RR, McEwen BS and Monder C (1991) Regional distribution of 11-hydroxysteroid dehydrogenase in rat brain. Endocrinology  128: 1741-1748[Abstract/Free Full Text].
• Lamacz M, Tonon MC, Smih-Rouet F, Patte C, Gasque P, Fontaine M and Vaudry H (1996) The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes. Mol Brain Res  37: 290-296[Medline].
• Leenders F, Adamski J, Husen B, Thole HH and Jungblut PW (1994a) Molecular cloning and amino acid sequence of the porcine 17-estradiol dehydrogenase. Eur J Biochem  222: 221-227[Medline].
• Leenders F, Husen B, Thole HH and Adamski J (1994b) The sequence of porcine 80 kDa 17-hydroxysteroid dehydrogenase reveals similarities to the short chain alcohol dehydrogenase family, to actin binding motifs and to sterol carrier protein 2. Mol Cell Endocrinol  104: 127-131[Medline].
• Le Goascogne C, Robel P, Gouézou M, Sananès N, Baulieu EE and Waterman M (1987) Neurosteroids: cytochrome P450scc in rat brain. Science (Wash DC)  237: 1212-1215[Abstract/Free Full Text].
• Le Goascogne C, Sananès N, Eychenne B, Gouézou M, Baulieu EE and Robel P (1995) Androgen biosynthesis in the stomach: expression of cytochrome P450 17-hydroxylase/17,20-lyase messenger ribonucleic acid and protein, and metabolism of pregnenolone and progesterone by parietal cells of the rat gastric mucosa. Endocrinology  136: 1744-1752[Abstract].
• Le Goascogne C, Sananès N, Gouézou M, Takemori S, Kominami S, Baulieu EE and Robel P (1991) Immunoreactive cytochrome P-450₁₇ in rat and guinea pig gonads, adrenal glands and brain. J Reprod Fertil  93: 609-622[Abstract/Free Full Text].
• Lephart ED (1993) Brain 5-reductase: Cellular, enzymatic, and molecular perspectives and implications for biological function. Mol Cell Neurosci  4: 473-484.
• Lephart ED (1996) A review of brain aromatase cytochrome P450. Brain Res Rev  22: 1-26[Medline].
• Lephart ED, Herbst MA and McPhaul MJ (1995) Characterization of aromatase cytochrome P-450 mRNA in rat perinatal brain, ovary, and a Leydig tumor cell line: Evidence for the existence of brain specific aromatase transcripts. Endocrine  3: 25-31.
• Lephart ED, Simpson ER and Ojeda SR (1992) Effect of cyclic AMP and androgens on in vitro brain aromatase enzyme activity during development in the rat. J Neuroendocrinol  4: 29-36.
• Lephart ED, Simpson ER and Trzeciak WH (1991) Rat adrenal 5-reductase mRNA content and enzyme activity are sex hormone dependent. J Mol Endocrinol  6: 163-170[Abstract/Free Full Text].
• Levallet J and Carreau S (1997) Expression in vitro du gène de l'aromatase dans les cellules testiculaires du rat. C R Acad Sci (Paris)  320: 123-129.
• Li XM, Salido EC, Kitada K, Serikawa T, Ten PH and Shapiro LJ (1996) Cloning of the rat steroid sulfatase gene (Sts), a non-pseudoautosomal X-linked gene that undergoes X inactivation. Mamm Genome  7: 420-424[Medline].
• Lihrmann I, Plaquevent JC, Tostivint H, Raijmakers R, Tonon MC, Conlon JM and Vaudry H (1994) Frog diazepam-binding inhibitor: peptide sequence, cDNA cloning, and expression in the brain. Proc Natl Acad Sci USA  91: 6899-6903[Abstract/Free Full Text].
• Lin HK and Penning TM (1995) Cloning, sequencing, and functional analysis of the 5'-flanking region of the rat 3-hydroxysteroid/dihydrodiol dehydrogenase gene. Cancer Res  55: 4105-4113[Abstract/Free Full Text].
• Low SC, Chapman KE, Edwards CRW and Seckl JR (1994) Liver-type 11-hydroxysteroid dehydrogenase cDNA encodes reductase not dehydrogenase activity in intact mammalian COS-7 cells. J Mol Endocrinol  13: 167-174[Abstract/Free Full Text].
• Luu-The V, Lachance Y, Labrie C, Leblanc G, Thomas JL, Strickler RC and Labrie F (1989) Full length cDNA structure and deduced amino acid sequence of human 3-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol  3: 1310-1312[Abstract/Free Full Text].
• Luu-The V, Sugimoto Y, Puy L, Labrie Y, Lopez SI, Singh M and Labrie F (1994) Characterization, expression, and immunohistochemical localization of 5-reductase in human skin. J Invest Dermatol  102: 221-226[Medline].
• Majewska MD (1992) Neurosteroids: endogenous bimodal modulators of the GABA_A receptor. Mechanism of action and physiological significance. Prog Neurobiol  38: 379-395[Medline].
• Malagon M, Vaudry H, Vallarino M, Gracia-Navarro F and Tonon MC (1992) Distribution and characterization of endozepine-like immunoreactivity in the central nervous system of the frog Rana ridibunda. Peptides  13: 99-107[Medline].
• Malagon M, Vaudry H, Van Strien F, Pelletier G, Gracia-Navarro F and Tonon MC (1993) Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain. Neuroscience  57: 777-786[Medline].
• Martel C, Melner MH, Gagné D, Simard J and Labrie F (1994) Widespread tissue distribution of steroid sulfatase, 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase (3-HSD), 17-HSD, 5-reductase and aromatase in the rhesus monkey. Mol Cell Endocrinol  104: 103-111[Medline].
• Martel C, Rhéaume E, Takahashi M, Trudel C, Couet J, Luu-The V, Simard J and Labrie F (1992) Distribution of 17-hydroxysteroid dehydrogenase gene expression and activity in rat and in human tissues. J Steroid Biochem Mol Biol  41: 597-603[Medline].
• Martini L, Celotti F and Melcangi RC (1996) Testosterone and progesterone metabolism in the central nervous system: cellular localization and mechanism of control of the enzymes involved. Cell Mol Neurobiol  16: 271-282[Medline].
• Mason JI (1993) The 3-hydroxysteroid dehydrogenase gene family of enzymes. Trends Endocrinol Metab  4: 199-203.
• Mason JI, Keeney DS, Bird IM, Rainey WE, Morohashi KI, Leers-Sucheta S and Melner MH (1997) The regulation of 3-hydroxysteroid dehydrogenase expression. Steroids  62: 164-168[Medline].
• McAllister JM and Hornsby PJ (1988) Dual regulation of 3 beta-hydroxysteroid dehydrogenase, 17 alpha-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3',5'-monophosphate and activators of protein kinase C in cultured human adrenocortical cells. Endocrinology  122: 2012-2018[Abstract/Free Full Text].
• McEwen BS (1994) Endocrine effects on the brain and their relationship to behavior, in Basic Neurochemistry (Siegel GJ, Agranoff BW, Albers RW andMolinoff B eds) pp 1003-1023, Raven Press, New York.
• McNatty KP, Baird DT, Bolton A, Chambers P, Corker CS and MacLean H (1976) Concentration of estrogens and androgens in human ovarian venous plasma and follicular fluid throughout the menstrual cycle. J Endocrinol  71: 77-85[Abstract/Free Full Text].
• McPhaul MJ, Noble JF, Simpson ER, Mendelson CR and Wilson D (1988) The expression of a functional cDNA encoding the chicken cytochrome P450arom (aromatase) that catalyzes the formation of estrogen from androgen. J Biol Chem  263: 16358-16363[Abstract/Free Full Text].
• Means GD, Mahendroo MS, Corbin CJ, Mathis MJ, Powell FE, Mendelson CR and Simpson ER (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem  264: 19385-19391[Abstract/Free Full Text].
• Melcangi RC, Celotti P, Castano P and Martini L (1993) Differential localization of the 5-reductase and the 3-hydroxysteroid dehydrogenase in neuronal and glial cultures. Endocrinology  132: 1252-1259[Abstract/Free Full Text].
• Melcangi RC, Celotti F and Martini L (1994) Progesterone 5-reduction in neuronal and in different types of glial cell cultures: type 1 and 2 astrocytes and oligodendrocytes. Brain Res  639: 202-206[Medline].
• Mellon S and Deschepper CF (1993) Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res  629: 283-292[Medline].
• Mellon-Nussbaum S and Hochberg RB (1980) Biosynthesis of lipoidal derivatives of pregnenolone and dehydroisoandrosterone by the adrenal. J Biol Chem  255: 5566-5572[Abstract/Free Full Text].
• Mensah-Nyagan AG, Feuilloley M, Do-Régo JL, Marcual A, Lange C, Pelletier G and Vaudry H (1996a) In vivo and in vitro evidence for the biosynthesis of testosterone in the telencephalon of the female frog. J Neurochem  67: 413-422[Medline].
• Mensah-Nyagan AG, Feuilloley M, Do-Régo JL, Marcual A, Lange C, Tonon MC, Pelletier G and Vaudry H (1996b) Localization of 17-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc Natl Acad Sci USA  93: 1423-1428[Abstract/Free Full Text].
• Mensah-Nyagan AG, Feuilloley M, Dupont E, Do-Régo JL, Leboulenger F, Pelletier G and Vaudry H (1994) Immunocytochemical localization and biological activity of 3-hydroxysteroid dehydrogenase in the central nervous system of the frog. J Neurosci  14: 7306-7318[Abstract].
• Miller WL (1988) Molecular biology of steroid hormone synthesis. Endocr Rev  9: 295-318[Abstract/Free Full Text].
• Mitani F, Ogishima T, Miyatomo H and Ishimura Y (1995) Localization of P450_aldo and P450₁₁ in normal and regenerating rat adrenal cortex. Endocr Res  21: 413-423[Medline].
• Miyabo S, Kishida S and Hisada T (1973) Metabolism and conjugation of cortisol by various dog tissue in vitro. J Steroid Biochem  4: 567-576[Medline].
• Moisan MP, Edwards CRW and Seckl JR (1992) Differential promoter usage by the rat 11-hydroxysteroid dehydrogenase gene. Mol Endocrinol  6: 1082-1087[Abstract/Free Full Text].
• Moisan MP, Seckl JR and Edwards CRW (1990) 11-Hydroxysteroid dehydrogenase bioactivity and messenger RNA expression in rat forebrain: Localization in hypothalamus, hippocampus and cortex. Endocrinology  127: 1450-1455[Abstract/Free Full Text].
• Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D and Edwards CRW (1989) Licorice inhibits corticosteroid 11-dehydrogenase of rat kidney and liver: In vivo and in vitro studies. Endocrinology  125: 1046-1053[Abstract/Free Full Text].
• Monnet FP, Mahe V, Robel P and Baulieu EE (1995) Neurosteroids via s receptors, modulate the [³H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci USA  92: 3774-3778[Abstract/Free Full Text].
• Moore CC, Brentano ST and Miller WL (1990) Human P450scc gene transcription is induced by cyclic AMP and repressed by 12-O-tetradecanoylphorbol-13-acetate and A23187 through independent cis elements. Mol Cell Biol  10: 6013-6023[Abstract/Free Full Text].
• Moore FL, Lowry CA and Rose JD (1994) Steroid-neuropeptide interactions that control reproductive behaviors in an amphibian. Psychoneuroendocrinology  19: 581-592[Medline].
• Mowszowicz I, Berthauit I, Mestayer C, Wright F, Kutten F and Mauvais-Jarvis P (1995) 5-Alpha-reductases: Physiology and pathology. Ann Endocrinol Paris  56: 555-559[Medline].
• Naftolin F, Ryan KJ, Davies IJ, Reddy VV, Flore F, Petro Z, Kuhn M, White RJ, Takaota Y and Wolin L (1975) The formation of estrogens by central neuroendocrine tissues. Recent Prog Horm Res  31: 295-319.
• Naftolin F, Ryan KJ and Petro Z (1972) Aromatization of androstenedione by the anterior hypothalamus of adult male and female rats. Endocrinology  90: 295-298[Abstract/Free Full Text].
• Nakajin S, Shively J, Yuan P and Hall P (1981) Microsomal cytochrome P450 from neonatal pig testis: Two enzymatic activities (17alpha hydroxylase and C17, 20 lyase) associated with one protein. Biochemistry  20: 4037-4042[Medline].
• Namiki M, Kitamura M, Buczko E and Dufau ML (1988) Rat testis P450₁₇ cDNA: The deduced amino acid sequence, expression and secondary structural configuration. Biochem Biophys Res Commun  157: 705-712[Medline].
• Naseeruddin SA and Hornsby PJ (1990) Regulation of 11 beta- and 17 alpha-hydroxylases in cultured bovine adrenocortical cells: 3',5'-cyclic adenosine monophosphate, insulin-like growth factor-I, and activators of protein kinase C. Endocrinology  127: 1673-1681[Abstract/Free Full Text].
• Negri-Cesi P, Colciago A and Celotti F (1996a) The role of aromatase in the brain, in The Brain: Source and Target for Sex Steroid Hormones (Gennazzani AR, Petraglia AF andPurdy RH eds) pp 135-149, The Parthenon Publishing Group, London.
• Negri-Cesi P, Poletti A and Celotti F (1996b) Metabolism of steroids in the brain: a new insight into the role of 5-reductase and aromatase in brain differentiation and functions. J Steroid Biochem Mol Biol  58: 455-466[Medline].
• Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O, Okuda K and Nebert DW (1993) The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol  12: 1-51[Medline].
• Nokelainen P, Peltoketo H, Vihko R and Vihko P (1998) Expression cloning of a novel estrogenic mouse 17-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol Endocrinol  12: 1048-1059[Abstract/Free Full Text].
• Normand T, Husen B, Leenders F, Pelczar H, Baret JL, Begue A, Flourens AC, Adamski J and de Launoit Y (1995) Molecular characterization of mouse 17-hydroxysteroid dehydrogenase IV. J Steroid Biochem Mol Biol  55: 541-548[Medline].
• Normington K and Russell DW (1992) Tissue distribution and kinetic characteristics of rat steroid 5-reductase isozymes. J Biol Chem  267: 19548-19554[Abstract/Free Full Text].
• Noshiro M, Nishimoto M, Morohashi KI and Okuda K (1989) Molecular cloning of cDNA for cholesterol 7-hydroxylase from rat liver microsomes. FEBS Lett  257: 97-100[Medline].
• Noshiro M and Okuda JY (1990) Molecular cloning and sequence analysis of cDNA encoding human cholesterol 7 alpha-hydroxylase. FEBS Lett  268: 137-140[Medline].
• Ogishima T, Suzuki H, Hata J, Mitani F and Ishimura Y (1992) Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 in rat adrenal cortex: histochemical basis for the functional zonation. Endocrinology  130: 2971-2977[Abstract/Free Full Text].
• Orchinik M, Murray TF, Franklin PH and Moore FL (1992) Guanyl nucleotides modulate binding to steroid receptors in neuronal membranes. Proc Natl Acad Sci USA  89: 3830-3834[Abstract/Free Full Text].
• Ozaki HS, Iwahashi K, Tsubaki M, Fukui Y, Ichikawa Y and Takeuchi Y (1991) Cytochrome P45011 in rat brain. J Neurosci Res  28: 518-524[Medline].
• Paden CM and Roselli CE (1987) Modulation of aromatase activity by testosterone in transplants of fetal rat hypothalamus-preoptic area. Dev Brain Res  33: 127-133.
• Panzica GC, Viglietti-Panzica C and Balthazart J (1996) The sexually dimorphic medial preoptic nucleus of quail: A key brain area mediating steroid action on male sexual behavior. Front Neuroendocrinol  17: 51-125[Medline].
• Papadopoulos V (1993) Peripheral-type benzodiazepine/diazepam-binding inhibitor receptor: Biological role in steroidogenic cell function. Endocr Rev  14: 222-240[Abstract/Free Full Text].
• Papadopoulos V and Guarneri P (1994) Regulation of C6 glioma cell steroidogenesis by adenosine 3',5'-cyclic monophosphate. Glia  10: 75-78[Medline].
• Papadopoulos V, Guarneri P, Krueger KE, Guidotti A and Costa E (1992) Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: Regulation by a mitochondrial diazepam-binding inhibitor receptor. Proc Natl Acad Sci USA  89: 5113-5117[Abstract/Free Full Text].
• Papadopoulos V, Mukhin AG, Costa E and Krueger KE (1990) The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem  265: 3772-3779[Abstract/Free Full Text].
• Park IH, Han BK and Jo DH (1997) Distribution and characterization of neurosteroid sulfatase from the bovine brain. J Steroid Biochem Mol Biol  62: 315-320[Medline].
• Patchev VK, Hassan AHS, Holsboer F and Almeida OFX (1996) The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology  15: 533-540[Medline].
• Patte C, Gandolfo P, Leprince J, Thoumas JL, Fontaine M, Vaudry H and Tonon MC (1999) GABA inhibits endozepine release from cultured rat astrocytes. Glia  25: 404-411[Medline].
• Patte C, Vaudry H, Desrues L, Gandolfo P, Strijdveen I, Lamacz M and Tonon MC (1995) The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes. FEBS Lett  362: 106-110[Medline].
• Pawlowski JE, Huizinga M and Penning TM (1991) Cloning and sequencing of the cDNA for rat liver 3-hydroxysteroid/dihydrodiol dehydrogenase. J Biol Chem  266: 8820-8825[Abstract/Free Full Text].
• Pelletier G, Liao N, Follea N and Govidan MV (1988) Mapping of estrogen receptor-producing cells in the rat by in situ hybridization. Neurosci Lett  94: 23-28[Medline].
• Pelletier G, Luu-The V and Labrie F (1994) Immunocytochemical localization of 5-reductase in the rat brain. Mol Cell Neurosci  5: 394-399[Medline].
• Pelletier G, Luu-The V and Labrie F (1995) Immunocytochemical localization of type I 17-hydroxysteroid dehydrogenase in the rat brain. Brain Res  704: 233-239[Medline].
• Peltoketo H, Isomaa V, Poutanen M and Vihko R (1996) Expression and regulation of 17-hydroxysteroid dehydrogenase type 1. J Endocrinol  150: S21-S30[Medline].
• Penning TM (1997) Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr Rev  18: 281-305[Abstract/Free Full Text].
• Penning TM, Pawlowski JE, Schlegel BP, Jez JM, Lin HK, Bennett MJ and Lewis M (1996) Mammalian 3-hydroxysteroid dehydrogenases. Steroids  61: 508-523[Medline].
• Phillips MD, Lakshmi V and Monder C (1989) Corticosteroid 11-dehydrogenase in rat testis. Endocrinology  125: 209-216[Abstract/Free Full Text].
• Piao YS, Peltoketo H, Oikarinen J and Vihko R (1995) Coordination of transcription of the human 17-hydroxysteroid dehydrogenase type 1 gene (EDH17B2) by a cell-specific enhancer and a silencer: Identification of a retinoic acid response element. Mol Endocrinol  9: 1633-1644[Abstract/Free Full Text].
• Puranen T, Poutanen M, Ghosh D, Vihko P and Vihko R (1997) Characterization of structural and functional properties of human 17-hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-directed mutagenesis. Mol Endocrinol  11: 77-86[Abstract/Free Full Text].
• Qin KN, New MI and Cheng KC (1993) Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol  46: 673-679[Medline].
• Rajan V, Chapman KE, Lyons V, Jamieson P, Mullins JJ, Edwards CRW and Seckl JR (1995) Cloning sequencing and tissue-distribution of mouse 11-hydroxysteroid dehydrogenase-1 cDNA. J Steroid Biochem Mol Biol  52: 141-147[Medline].
• Rajkowski KM, Robel P and Baulieu EE (1997) Hydroxysteroid sulfotransferase activity in the rat brain and liver as a function of age and sex. Steroids  62: 427-436[Medline].
• Ramirez VD and Zheng J (1996) Membrane sex-steroid receptors in the brain. Front Neuroendocrinol  17: 402-439[Medline].
• Reddy VVR (1979) Estrogen metabolism in neural tissues of rabbits: 17-hydroxysteroid dehydrogenase oxidoreductase activity. Steroids  34: 207-215[Medline].
• Resko JA, Stadelman HL and Norman RL (1979) 17-hydroxysteroid dehydrogenase activity in the pituitary gland and neural tissue of rhesus monkey. J Steroid Biochem  11: 1429-1434[Medline].
• Rhéaume E, Lachance Y, Zhao HF, De Launoit Y, Trudel C, Luu-The V, Simard J and Labrie F (1991) Structure and expression of a new cDNA encoding the almost exclusive 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase in human adrenals and gonads. Mol Endocrinol  5: 1147-1157[Abstract/Free Full Text].
• Rhéaume E, Tonon MC, Smih F, Simard F, Desy L, Vaudry H and Pelletier G (1990) Localization of the endogenous benzodiazepine ligand octadecaneuropeptide in the rat testis. Endocrinology  127: 1986-1994[Abstract/Free Full Text].
• Robel P and Baulieu EE (1985) Neuro-steroids: 3-Hydroxy-⁵-derivates in the rodent brain. Neurochem Int  7: 953-958.
• Robel P and Baulieu EE (1994) Neurosteroids: Biosynthesis and function. Trends Endocrinol Metab  5: 1-8.
• Robel P, Bourreau E, Corpéchot C, Dang DC, Halberg F, Clarke C, Haug M, Sclegel ML, Synguelakis M, Vourc'h C and Baulieu EE (1987) Neurosteroids: 3-Hydroxy-⁵-derivatives in rat and monkey brain. J Steroid Biochem  27: 649-655[Medline].
• Robel P, Corpéchot C, Clarke C, Groyer A, Synguelakis M, Vourc'h C and Baulieu EE (1986) Neurosteroids: 3-Hydroxy-⁵-derivatives in the rat brain, in Neuroendocrine Molecular Biology (Fink AJ, Harmar AJ andMc Kerns KW eds) pp 367-377, Plenum Press, New York.
• Robel P, Young J, Corpéchot C, Mayo W, Perche F, Haug M, Simon H and Baulieu EE (1995) Biosynthesis and assay of neurosteroids in rats and mice: functional correlates. J Steroid Biochem Mol Biol  53: 355-360[Medline].
• Roland BL, Li KXZ and Funder JW (1995) Hybridization histochemical localization of 11-hydroxysteroid dehydrogenase type 2 in rat brain. Endocrinology  136: 4697-4700[Abstract].
• Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, Russel DW, Bjorkhem I, Seckl J and Lathe R (1997) Cyp7, a novel brain cytochrome P450, catalyses the synthesis of neurosteroids 7-hydroxy dehydroepiandrosterone and 7-hydroxy pregnenolone. Proc Natl Acad Sci USA  94: 4925-4930[Abstract/Free Full Text].
• Roselli CE, Abdelgadir SE, Jorgensen E and Resko JA (1996a) Sex differences in androgen-regulated cytochrome P450 aromatase mRNA in the rat brain. Endocrine  5: 59-65.
• Roselli CE, Abdelgadir SE and Resko JA (1997) Regulation of aromatase gene expression in the adult rat brain. Brain Res Bull  44: 351-357[Medline].
• Roselli CE and Fasasi TE (1992) Estradiol increases the duration of nuclear androgen receptor occupation in the preoptic area of male rat treated with dihydrotestosterone. J Steroid Biochem Mol Biol  42: 161-168[Medline].
• Roselli CE, Horton LE and Resko JA (1985) Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology  117: 2471-2477[Abstract/Free Full Text].
• Roselli CE, Klosterman SA and Fasasi TA (1996b) Sex differences in androgen responsiveness in the rat brain: Regional differences in the induction of aromatase activity. Neuroendocrinology  64: 139-145[Medline].
• Roselli CE and Resko JA (1993) Aromatase activity in the rat brain: hormonal regulation and sex differences. J Steroid Biochem Mol Biol  44: 499-508[Medline].
• Roselli CE, Stadelman H, Horton LE and Resko JA (1987) Regulation of androgen metabolism and luteinizing hormone-releasing content in discreet hypothalamic and limbic areas of male rhesus macaques. Endocrinology  120: 97-106[Abstract/Free Full Text].
• Rouet-Smih F, Tonon MC, Pelletier G and Vaudry H (1992) Characterization of endozepine-related peptides in the central nervous system and in peripheral tissues of the rat. Peptides  13: 1219-1225[Medline].
• Rusvai E and Naray-Fejes-Toth A (1993) A new isoform of 11-hydroxysteroid dehydrogenase in aldosterone target cells. J Biol Chem  268: 10717-10720[Abstract/Free Full Text].
• Saitoh H, Hirato K, Yanaihara T and Nakayama T (1982) A study of 5-reductase in human fetal brain. Endocrinol Jpn  29: 461-467[Medline].
• Salido EC, Li XM, Yen PH, Martin N, Mohandas TK and Shapiro LJ (1996) Cloning and expression of the mouse pseudoautosomal steroid sulphatase gene (Sts). Nat Genet  13: 83-86[Medline].
• Sanghera MK, Simpson ER, McPhaul MJ, Kozlowski G, Conley AJ and Lephart ED (1991) Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies. Endocrinology  129: 2834-2844[Abstract/Free Full Text].
• Sapolsky RM (1996) Why is the stress bad for your brain? Science (Wash DC)  273: 749-750[Medline].
• Schumacher M, Robel P and Baulieu EE (1996) Development and regeneration of the nervous system: A role for neurosteroids. Dev Neurosci  18: 6-21[Medline].
• Seckl JR (1997) 11-hydroxysteroid dehydrogenase in the brain: A novel regulator of glucocorticoid action. Front Neuroendocrinol  18: 49-99[Medline].
• Seckl JR, Brown RW, Rajan V, Low SC and Edwards CRW (1993) 11-Hydroxysteroid dehydrogenase and corticosteroid actions in the brain. J Endocrinol  137: 9.
• Sherwood NM, Lovejoy DA and Coe IR (1993) Origin of mammalian gonadotropin-releasing hormones. Endocr Rev  14: 241-254[Abstract/Free Full Text].
• Shinoda K, Shiotani Y and Osawa Y (1989a) "Necklace olfactory glomeruli" form unique components of the rat primary olfactory system. J Comp Neurol  284: 362-373[Medline].
• Shinoda K, Yagi H, Fujita H, Osawa Y and Shiotani Y (1989b) Screening of aromatase containing-neurons in rat forebrain: An immunohistochemical study with antibody against human placental antigen X-P2 (hPAX-P2). J Comp Neurol  290: 502-515[Medline].
• Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, Swynghedauw B and Delcayre C (1998) Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem  273: 4883-4891[Abstract/Free Full Text].
• Simard J, Durocher F, Mebarki F, Sanchez R, Labrie Y, Couet J, Trudel C, Rhéaume E, Morel Y, Luu-The V and Labrie F (1996) Molecular biology and genetics of the 3-hydroxysteroid dehydrogenase/⁵-⁴ isomerase gene family. J Endocrinol  150: S189-S207[Medline].
• Simpson ER, Merrill JC, Hollub AJ, Graham-Lorence S and Mendelson CR (1989) Regulation of estrogen biosynthesis by human adipose cells. Endocr Rev  10: 136-148[Abstract/Free Full Text].
• Slobodyansky E, Antkiewicz-Michaluk L and Martin B (1994) Purification of a novel DBI processing product, DBI_39-75, and characterization of its binding site in rat brain. Regul Pept  50: 29-35[Medline].
• Slobodyansky E, Kurriger G and Kultas-Ilinsky K (1992) Diazepam binding inhibitor processing in the rhesus monkey brain: an immunocytochemical study. J Chem Neuroanat  5: 169-180[Medline].
• Stapleton G, Steel M, Richardson M, Mason JO, Rose KA, Morris RGM and Lathe R (1995) A novel cytochrome P450 expressed primarily in brain. J Biol Chem  270: 29739-29745[Abstract/Free Full Text].
• Strömstedt M and Waterman MR (1995) Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain. Mol Brain Res  34: 75-88[Medline].
• Strott C (1996) Steroid sulfotransferases. Endocr Rev  17: 670-697[Abstract/Free Full Text].
• Tanaka M, Telecky TM, Fukada S, Adachi S, Chen S and Nagahama Y (1992) Cloning and sequence analysis of the cDNA encoding P450 aromatase (P450arom) from a rainbow trout (Oncorhynchus mykiss) ovary; relationship between the amount of P450arom mRNA and the production of oestradiol-17 in the ovary. J Mol Endocrinol  8: 53-61[Abstract/Free Full Text].
• Tannin GM, Agarwal AK, Monder C, New MI and White PC (1991) The human gene for 11-hydroxysteroid dehydrogenase. J Biol Chem  266: 16653-16658[Abstract/Free Full Text].
• Terashima M, Toda K, Kawamoto T, Kuribayashi I, Ogawa Y, Maeda T and Shizuta Y (1991) Isolation of a full-length cDNA encoding mouse aromatase P450. Arch Biochem Biophys  285: 231-237[Medline].
• Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD and Russell DW (1993) Tissue distribution and ontogeny of steroid 5-reductase isozyme expression. J Clin Invest  92: 903-910.
• Toda K, Terashima M, Kawamoto T, Sumimoto H, Yokoyama Y, Kuribayashi I, Mitsuuchi Y, Maeda T, Yamamoto Y, Sagara Y, Ikeda H and Shizuta Y (1990) Structural and functional characterization of human aromatase P450 gene. Eur J Biochem  193: 559-565[Medline].
• Tong Y, Toranzo D and Pelletier G (1991) Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides  20: 433-443.
• Tonon MC, Smih-Rouet F, Lamacz M, Louiset E, Pelletier G and Vaudry H (1994) Endozepines: endogenous ligands for benzodiazepine receptors. Med/Sci  10: 433-443.
• Toranzo D, Tong Y, Tonon MC, Vaudry H and Pelletier G (1994) Localization of diazepam-binding inhibitor and peripheral type benzodiazepine binding sites in the rat ovary. Anat Embryol  979: 383-388.
• Torran-Allerand CD, Miranda RC, Hochberg RB and MacLusky NJ (1992) Cellular variations in estrogen receptor mRNA translation in the developing brain: Evidence from combined [¹²⁵I]estrogen autoradiography and non-isotopic in situ hybridization histochemistry. Brain Res  576: 25-41[Medline].
• Tremblay Y and Beaudouin C (1993) Regulation of 3 beta-hydroxysteroid dehydrogenase and 17 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cylic adenosine 3', 5'-monophosphate and phorbol myristate acetate in human choriocarcinoma cells. Mol Endocrinol  7: 355-364[Abstract/Free Full Text].
• Tsuruo Y, Ishimura K, Fujita H and Osawa Y (1994) Immunocytochemical localization of aromatase-containing neurons in the rat brain during pre- and postnatal development. Cell Tissue Res  278: 29-39[Medline].
• Tsuruo Y, Miyamoto T, Yokoi H, Kitagawa K, Futaki S and Ishimura K (1996) Immunohistochemical presence of 5-reductase rat type 1-containing cells in rat brain. Brain Res  722: 207-211[Medline].
• Tsutsui K and Yamazaki T (1995) Avian neurosteroids. 1. Pregnenolone biosynthesis in the quail brain. Brain Res  678: 1-9[Medline].
• Ukena K, Usui M, Kohchi C and Tsutsui K (1998) Cyotchrome P450 side-chain cleavage enzyme in the cerebellar purkinje neuron and its neonatal change in rats. Endocrinology  139: 137-147[Abstract/Free Full Text].
• Uno H, Tarara R, Else JG, Suleman MA and Sapolsky R (1989) Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci  9: 1705-1711[Abstract].
• Usui M, Yamazaki T, Kominami S and Tsutsui K (1995) Avian neurosteroids. 2. Localization of a cytochrome P450scc-like substance in the quail brain. Brain Res  678: 10-20[Medline].
• Valera S, Ballivet M and Bertrand D (1992) Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA  89: 9949-9953[Abstract/Free Full Text].
• Valladares LE and Payne AH (1979) Induction of testicular aromatization by luteinizing hormone in mature rats. Endocrinology  105: 431-436[Abstract/Free Full Text].
• Vanson A, Arnold AP and Schlinger BA (1996) 3-hydroxysteroid dehydrogenase/isomerase and aromatase activity in primary cultures of developing zebra finch telencephalon: dehydroepiandrosterone as substrate for synthesis of androstenedione and estrogens. Gen Comp Endocrinol  102: 342-350[Medline].
• Vourc'h C, Eychenne B, Jo DH, Raulin J, Lapous D, Baulieu EE and Robel P (1992) ⁵-3-hydroxysteroid acyl transferase activity in the rat brain. Steroids  57: 210-214[Medline].
• Warner M, Strömstedt M, Moller L and Gustafsson G (1989) Distribution and regulation of 5-androstane-3, 17-diol hydroxylase in the rat central nervous system. Endocrinology  124: 2699-2706[Abstract/Free Full Text].
• Watanabe N, Inoue H and Fujii-Kuriyama Y (1994) Regulatory mechanisms of cAMP-dependent and cell-specific expression of human steroidogenic cytochrome P450scc (CYP11A1) gene. Eur J Biochem  222: 825-834[Medline].
• Weaver CE, Jr, Marek P, Park-Chung M, Tam SW and Farb DK (1997) Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA  94: 10450-10454[Abstract/Free Full Text].
• Webb EC (1992) Enzyme Nomenclature (Webb EC ed) pp 299-303, Academic Press, New York.
• Wehrenberg WB, Corder R and Gaillard RC (1989) A physiological role for neuropeptide Y in regulating the estrogen/progesterone induced luteinizing hormone surge in ovariectomized rats. Neuroendocrinology  49: 680-682[Medline].
• Weidenfield J, Sziegel RA and Chowers I (1980) In vitro conversion of pregnenolone to progesterone by discrete brain areas of the male rat. J Steroid Biochem  13: 961-963[Medline].
• Wilson JD (1975) Metabolism of testicular androgens, in Handbook of Physiology (Greep RO andAstwood EB eds) pp 491-508, American Physiological Society, Washington, DC..
• Winslow JT, Hastings N, Carter CS, Harbaugh CR and Insel TR (1993) A role for central vasopressin in pair bonding in monogamous prairie voles. Nature (London)  365: 545-548[Medline].
• Wu FS, Gibbs TT and Farb DH (1991) Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol  40: 333-336[Abstract].
• Yabu M, Senda T, Nonaka Y, Matsukawa N, Okamoto M and Fujita H (1991) Localization of the gene transcripts of 11-hydroxylase and aldosterone synthase in the rat adrenal cortex by in situ hybridization. Histochemistry  96: 391-394[Medline].
• Yang K, Smith CL, Dales D, Hammond GL and Challis JR (1992) Cloning of an ovine 11 beta-hydroxysteroid dehydrogenase complementary deoxyribonucleic acid: Tissue and temporal distribution of its messenger ribonucleic acid during fetal and neonatal development. Endocrinology  131: 2120-2126[Abstract/Free Full Text].
• Yu WH (1989) Survival of motoneurons following axotomy is enhanced by lactation or by progesterone treatment. Brain Res  491: 379-382[Medline].
• Yuan H, Bowlby DA, Brown TJ, Hochberg RB and MacLusky NJ (1995) Distribution of occupied and unoccupied estrogen receptors in the rat brain: Effects of physiological gonadal steroid exposure. Endocrinology  136: 96-105[Abstract].
• Zavala F and Lenfant M (1987) Peripheral benzodiazepines enhance the respiratory burst of macrophage-like P 388D₁ cells stimulated by arachidonic acid. Int J Immunopharmacol  9: 269-274[Medline].
• Zhang P, Rodriguez H and Mellon S (1995) Transcriptional regulation of P450scc gene expression in neural and steroidogenic cells: implication for regulation for neurosteroidogenesis. Mol Endocrinol  9: 1571-1582[Abstract/Free Full Text].
• Zhao HF, Labrie C, Simard J, de Launoit Y, Trudel C, Martel C, Rhéaume E, Dupont E, Luu-The V, Pelletier G and Labrie L (1991) Characterization of 3-hydroxysteroid dehydrogenase ⁵-⁴ isomerase cDNA and differential tissue-specific expression of the corresponding mRNAs in steroidogenic and peripheral tissues. J Biol Chem  266: 583-593[Abstract/Free Full Text].
• Zhao HF, Rhéaume E, Trudel C, Couet J, Labrie F and Simard J (1990) Structure and sexual dimorphic expression of a liver-specific rat 3-hydroxysteroid dehydrogenase/isomerase. Endocrinology  127: 3237-3239[Abstract/Free Full Text].
• Zhou MY, Gomez-Sanchez EP, Cosby D and Gomez-Sanchez CE (1995) Cloning of a NAD⁺-dependent 11-hydroxysteroid dehydrogenase from rat kidney. Endocr Soc Abstr  77: 413.

0031-6997/99/511-0063$03.00/0
PHARMACOLOGICAL REVIEWS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				P. Micevych and K. Sinchak Synthesis and Function of Hypothalamic Neuroprogesterone in Reproduction Endocrinology, June 1, 2008; 149(6): 2739 - 2742. [Abstract] [Full Text] [PDF]

				A. E. M. Newman, D. S. Pradhan, and K. K. Soma Dehydroepiandrosterone and Corticosterone Are Regulated by Season and Acute Stress in a Wild Songbird: Jugular Versus Brachial Plasma Endocrinology, May 1, 2008; 149(5): 2537 - 2545. [Abstract] [Full Text] [PDF]

				C. Kibaly, L. Meyer, C. Patte-Mensah, and A. G. Mensah-Nyagan Biochemical and functional evidence for the control of pain mechanisms by dehydroepiandrosterone endogenously synthesized in the spinal cord FASEB J, January 1, 2008; 22(1): 93 - 104. [Abstract] [Full Text] [PDF]

				H. Ish, T. Tsurugizawa, M. Ogiue-Ikeda, M. Asashima, H. Mukai, G. Murakami, Y. Hojo, T. Kimoto, and S. Kawato Local Production of Sex Hormones and Their Modulation of Hippocampal Synaptic Plasticity Neuroscientist, August 1, 2007; 13(4): 323 - 334. [Abstract] [PDF]

				S. E. London, D. A. Monks, J. Wade, and B. A. Schlinger Widespread Capacity for Steroid Synthesis in the Avian Brain and Song System Endocrinology, December 1, 2006; 147(12): 5975 - 5987. [Abstract] [Full Text] [PDF]

				J M Torres and E Ortega Steroid 5{alpha}-reductase isozymes in the adult female rat brain: central role of dihydrotestosterone. J. Mol. Endocrinol., April 1, 2006; 36(2): 239 - 245. [Abstract] [Full Text] [PDF]

				M. J. Ebner, D. I. Corol, H. Havlikova, J. W. Honour, and J. P. Fry Identification of Neuroactive Steroids and Their Precursors and Metabolites in Adult Male Rat Brain Endocrinology, January 1, 2006; 147(1): 179 - 190. [Abstract] [Full Text] [PDF]

				C. Patte-Mensah, C. Kibaly, and A. G. Mensah-Nyagan Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: A potential component of nociception PNAS, June 21, 2005; 102(25): 9044 - 9049. [Abstract] [Full Text] [PDF]

				J Miao, K-W Chan, G G Chen, S-Y Chun, N-S Xia, J Y H Chan, and N S Panesar Blocking BRE expression in Leydig cells inhibits steroidogenesis by down-regulating 3{beta}-hydroxysteroid dehydrogenase J. Endocrinol., June 1, 2005; 185(3): 507 - 517. [Abstract] [Full Text] [PDF]

				J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF]

				A. H. Payne and D. B. Hales Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones Endocr. Rev., December 1, 2004; 25(6): 947 - 970. [Abstract] [Full Text] [PDF]

				D. S. Reddy, D. C. Castaneda, B. W. O'Malley, and M. A. Rogawski Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 230 - 239. [Abstract] [Full Text] [PDF]

				I. Charalampopoulos, C. Tsatsanis, E. Dermitzaki, V.-I. Alexaki, E. Castanas, A. N. Margioris, and A. Gravanis Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins PNAS, May 25, 2004; 101(21): 8209 - 8214. [Abstract] [Full Text] [PDF]

				F. Hammer, N. A. Compagnone, J.-L. Vigne, S. R. Bair, and S. H. Mellon Transcriptional Regulation of P450scc Gene Expression in the Embryonic Rodent Nervous System Endocrinology, February 1, 2004; 145(2): 901 - 912. [Abstract] [Full Text] [PDF]

				Y. Hojo, T.-a. Hattori, T. Enami, A. Furukawa, K. Suzuki, H.-t. Ishii, H. Mukai, J. H. Morrison, W. G. M. Janssen, S. Kominami, et al. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017{alpha} and P450 aromatase localized in neurons PNAS, January 20, 2004; 101(3): 865 - 870. [Abstract] [Full Text] [PDF]

				P. M. Apaja, K. T. Harju, J. T. Aatsinki, U. E. Petaja-Repo, and H. J. Rajaniemi Identification and Structural Characterization of the Neuronal Luteinizing Hormone Receptor Associated with Sensory Systems J. Biol. Chem., January 16, 2004; 279(3): 1899 - 1906. [Abstract] [Full Text] [PDF]

				M. De Roo, J.-L. Rodeau, and R. Schlichter Dehydroepiandrosterone Potentiates Native Ionotropic ATP Receptors Containing the P2X2 Subunit in Rat Sensory Neurones J. Physiol., October 1, 2003; 552(1): 59 - 71. [Abstract] [Full Text] [PDF]

				L. N Eisenman, Y. He, C. Fields, C. F Zorumski, and S. Mennerick Activation-Dependent Properties of Pregnenolone Sulfate Inhibition of GABAA Receptor-Mediated Current J. Physiol., August 1, 2003; 550(3): 679 - 691. [Abstract] [Full Text] [PDF]

				D. Beaujean, J.-L. Do-Rego, L. Galas, A. G. Mensah-Nyagan, R. Fredriksson, D. Larhammar, A. Fournier, V. Luu-The, G. Pelletier, and H. Vaudry Neuropeptide Y Inhibits the Biosynthesis of Sulfated Neurosteroids in the Hypothalamus through Activation of Y1 Receptors Endocrinology, May 1, 2002; 143(5): 1950 - 1963. [Abstract] [Full Text] [PDF]

				D. S. Reddy and M. A. Rogawski Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABAA Receptor Function and Seizure Susceptibility J. Neurosci., May 1, 2002; 22(9): 3795 - 3805. [Abstract] [Full Text] [PDF]

				J. A. Sim, M. J. Skynner, and A. E. Herbison Direct Regulation of Postnatal GnRH Neurons by the Progesterone Derivative Allopregnanolone in the Mouse Endocrinology, October 1, 2001; 142(10): 4448 - 4453. [Abstract] [Full Text] [PDF]

				G. Akk, J. Bracamontes, and J. H. Steinbach Pregnenolone sulfate block of GABAA receptors: mechanism and involvement of a residue in the M2 region of the {alpha} subunit J. Physiol., May 1, 2001; 532(3): 673 - 684. [Abstract] [Full Text] [PDF]

				J. L. Do-Rego, G. A. Mensah-Nyagan, D. Beaujean, D. Vaudry, W. Sieghart, V. Luu-The, G. Pelletier, and H. Vaudry gamma -Aminobutyric acid, acting through gamma -aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus PNAS, November 16, 2000; (2000) 240269897. [Abstract] [Full Text]

				P. Follesa, M. Serra, E. Cagetti, M. G. Pisu, S. Porta, S. Floris, F. Massa, E. Sanna, and G. Biggio Allopregnanolone Synthesis in Cerebellar Granule Cells: Roles in Regulation of GABAA Receptor Expression and Function during Progesterone Treatment and Withdrawal Mol. Pharmacol., June 1, 2000; 57(6): 1262 - 1270. [Abstract] [Full Text]

				W. Shen, S. Mennerick, D. F. Covey, and C. F. Zorumski Pregnenolone Sulfate Modulates Inhibitory Synaptic Transmission by Enhancing GABAA Receptor Desensitization J. Neurosci., May 15, 2000; 20(10): 3571 - 3579. [Abstract] [Full Text] [PDF]

				L. D. Griffin and S. H. Mellon Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes PNAS, November 9, 1999; 96(23): 13512 - 13517. [Abstract] [Full Text] [PDF]

				J. L. Do-Rego, G. A. Mensah-Nyagan, D. Beaujean, D. Vaudry, W. Sieghart, V. Luu-The, G. Pelletier, and H. Vaudry gamma -Aminobutyric acid, acting through gamma -aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus PNAS, December 5, 2000; 97(25): 13925 - 13930. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mensah-Nyagan, A. G. Articles by Vaudry, H. Search for Related Content PubMed PubMed Citation Articles by Mensah-Nyagan, A. G. Articles by Vaudry, H.